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Zambia's antenatal HIV prevalence of 19% is among the highest in the world. As 
part of the response to this epidemic the Zambian government has committed itself to 
scaling up Prevention of Mother to Child Transmission (PMTCT) services to the 
following targets: 90 per cent utilization of antenatal care, 70 per cent uptake of 
voluntary counseling and testing services (VCT), 75 per cent adherence to nevirapine 
antiretroviral therapy and 85 per cent adherence to follow up testing of HIV exposed 
babies by 2008. Even though the cost-effectiveness of nevirapine antiretroviral 
therapy to reduce mother-to-child transmission (MTCT) of HIV is well established, 
there has been no examination of the resources required to scale up PMTCT to the 
proposed Zambian national targets. The purpose of this study was to estimate the 
costs and human resource requirements of scaling up PMTCT to the proposed targets. 
Estimates are compared with the proposed 2006-2008 medium term expenditure 
estimates and projected staffing levels to ascertain the feasibility of reaching the 
proposed targets. 
Data on the demographics, antenatal HIV prevalence, human resources, envisaged 
nature of PMTCT service delivery and proposed utilization targets of the scale up 
program were obtained by conducting semi-structured interviews with key informants 
and reviewing key policy documents. This was undertaken at the central level which 
includes the Ministry of Health and its implementation body known as the Central 
Board· of Health (CBoH). A full cost analysis, from the public health system 
perspective, was undertaken at 2 selected pilot site facilities to calculate the unit costs 
associated with PMTCT. One rural and one urban health facility was selected using 
stratified random sampling to take into account possible variations due to 
geographical positioning. By combining these unit costs with the proposed utilization 
targets, the costs of scaling up were estimated. Human resource requirements for 
scaling up PMTCT were estimated based on the observed time to complete each 
program element (pre-test counseling, testing, post-test counseling, delivery and 
follow up) in the selected facilities. All quantitative data were analyzed usmg 












Some of the major findings from the analysis were; 
• 	 In both facilities, VCT costs (i.e. pre-test counseling, testing, post-test counseling) 
were the largest component accounting for 84% of the total direct costs. This was 
mainly related to the high acceptance of VCT services (>90%) and high cost of 
the mv screening (US$1.38) and confirmatory test (US$3.69) in the facilities. 
• 	 The unit costs of providing PMTCT were higher in the rural facility than in the 
urban facility. This gives some indication of the diseconomies of scale associated 
with scaling up to rural areas and potential economies of scale associated with the 
extra one year maturation period in the urban facility. 
• 	 Difficulties associated with reaching PMTCT targets were highlighted as a non­
negligible proportion of women were lost to follow-up at each phase, mainly at 
the delivery and follow up stage of the PMTCT program. The drop out rates 
indicated that follow up testing for infants has been the most challenging element 
with 59% and 88% failing to adhere to follow up testing in the urban and rural 
facilities respectively. 
• 	 It was estimated that the total direct costs of scaling up over a three year period 
(2006-2008) would be US$24.3 million with VCT costs accounting for more than 
70% of the total costs in each year. However, the results of this study have 
highlighted a possible budgetary deficit of at least US$5.06 million when these 
costs are compared to the 2006-2008 M1EF estimates. 
• 	 The analysis suggests that there would be significant cost reductions in scaling up 
PMTCT if mv prevalence were to decline. This reinforces the approach of 
prevention of primary HIV infection as outlined in the internationally accepted 
four prong approach to implementing PMTCT. 
• 	 The study found that 476 full time equivalent (F1E) midwives would need to be 
recruited to deliver the proposed scaled up PMTCT services in 2008. However, 
the analysis estimates that when the staffing levels, attrition rates and annual 
graduates in the public sector are taken into account, the projected number of 











2008 PMTCT workload. In addition to these shortages, imbalances in staffing 
which favour urban sites, threaten the scale up program to rural areas. 
In conclusion, some of the policy recommendations that have been drawn from the 
study findings include; 
• 	 In the advent of cheap ARV drugs, the next challenge lies in reducing costs of 
HIV testing. Using cheaper but effective testing methods such as finger prick 
method as opposed to drawing blood with syringes should be considered. 
• 	 In light of the possible budgetary constraints in the scale up program, Government 
is urged to mobilize and allocate adequate resources to the program. Government 
must take advantage of unprecedented international commitment and funding 
sources such as the Global fund to fight HIV/AIDS, Tuberculosis and Malaria 
(GFATM) to mobilize more resources for scaling up PMTCT. 
• 	 In order to improve uptake rates in the facilities the following are recommended; 
1) encouraging male involvement in VCT to help reduce stigma and increase the 
number of women who enroll into the PMTCT program; 2) assigning new roles to 
traditional birth attendants such as VCT, following-up antenatal and postnatal 
women in communities and assisting in monitoring adherence to nevirapine for 
the large proportion of women who deliver at home. 
A multifaceted approach to dealing with the human resource shortages is 
recommended. It includes; 
• 	 Introducing financial and non-financial incentives to motivate and retain a greater 
number of staff. 
• 	 Improving recruitment and deployment practices, by basing them on existing staff 
imbalances, would help scale up services to rural areas. 
• 	 Making greater investments in pre-service training in order to produce the 
requisite quantity and quality of staff for PMTCT services. 
• 	 Recruiting cheaper cadres like traditional birth attendants to provide services like 
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transmission rate without intervention, 5 to 10 per cent will be as a result of 
transmission through pregnancy, 10 to 20 per cent during labour and 5 to 10 per cent 
through breastfeeding (Hira 1989). Given the high mv prevalence and this 
transmission risk, of the 550,000 babies born annually in Zambia, 103,000 could be 
born to an mv-positive mother, which would imply approximately 40,000 acquiring 
mv infection without intervention. This translates to about 110 new infections in 
babies per day (Central Board of Health (CBOH) 2003). The majority of those 
infected will die before their second birthday (UNICEF 2003). 
The implementation of Prevention of Mother to Child Transmission (PMTCT) of mv 
programmes has yielded positive results in developed countries and in Thailand, a 
middle-income country, where the mother to child transmission (MTCT) rates have 
been reduced to less than 2 per cent and 10 per cent respectively (Central Board of 
Health (CBOH) 2003; UNAIDS 2003b; Family Health International 2004; World 
Health Organisation (WHO) 2004a). If the Zambian program is to have significant 
impact on childhood mv infection and increasing mortality trends, PMTCT services 
need to be scaled up to all Maternal Child Health (MCH) services in the country. 
Scaling up includes four key strategies: prevention of primary infection, prevention 
of pregnancy in mv infected women, prevention of mother to child transmission 
using ARVs and care and support of infected families (Luo 2000; Ministry of Health 
2003; Ministry of Health 2006). 
At health facility level, strategies planned include improving antenatal and postnatal 
utilization to 90 per cent, acceptance of VCT to 70 per cent, acceptance and 
adherence to ARV therapy by mv positive women to 75 per cent and ensuring clean 
and safe deliveries in the health facility and the home (Central Board of Health 
(CBOH) 2003; Ministry of Health 2006). This package includes voluntary 
counselling and testing (VCT) for mv and the provision of Nevirapine (NVP) 
according to the mVNET 012 regimen to all pregnant women who test positive for 
HIV (Guay, Musoke et al. 1999; Central Board of Health (CBOH) 2003). The phase­
in plan includes the successive addition of new districts to the PMTCT program, and 
then devolution of program activities from central facilities to more accessible district 











In order for the country to put in place an effective scale up program there is a need to 
understand costs, systems and process implications. This will help to allocate scarce 
resources to the most cost-effective methods (Wilkinson, Floyd et al. 1999; Scotland, 
Terjlingen et al. 2003). In addressing this issue, the study will be looking at available 
pilot on-site information to describe some of these implications. 
1.1 Problem Statement 
Similar to many of the sub-Saharan African countries, Zambia is experiencing an 
HIV/AIDS epidemic that has affected every aspect of the population's socio­
economic wellbeing. In 2001, Zambia was part of the 189 countries at the United 
Nations General Assembly Special Session (UNGASS) on HIV/AIDS that committed 
themselves to a comprehensive program of international and national action to fight 
HIV/AIDS by adopting the Declaration of Commitment on HIV/AIDS (UNAIDS 
2003b). The Declaration established specific goals, which included reducing the 
proportion of infants with HIV by 20% by 2005 and 50% by 2010 (UNAIDS 2003b). 
For this to become reality there is a need to increase access for pregnant mothers to 
information, counseling services and other HIV prevention services. In addition, 
there is a need to increase availability and access to effective ARV prophylaxis to 
infected women in order to reduce the MTCT of HIV while ensuring that the quality 
of these services are not undermined (AIDS Campaign Team for Africa (ACTafrica) 
2001; Stover, Walker et al. 2002; Central Board of Health (CBOH) 2003; Family 
Health International 2004). 
However due to the limited amount of resources available to the government there is a 
need to understand the implications for costs, infrastructure and delivery of such a 
service. Therefore, in order to make policy recommendations, there is further need to 
understand the most efficient way of scaling up and using such limited resources. A 













1.3 Justification/Rationale for the Study 
Since 1991, Zambia has embarked on an ambitious health reforms program, whose 
vision has been" to provide Zambians. with equity of access to cost-effective, quality 
health care as close to the family as possible" (Central Board of Health (CBOH) 
2003). The effort to improve access to PMTCT services clearly falls within the 
country's health vision. However like most developing countries, there are 
tremendous challenges to achieving these objectives. The reoccurring theme of 
limited and inadequate resources has hampered the speed of implementing such 
reforms (Central Board of Health (CBOH) 2004). In anticipation of increased 
resources from debt relief and global funds, Zambia plans to use this additional 
funding to scale up PMTCT services to a greater number. However, at the same time, 
the health system faces many other challenges such as the inability to maintain 
adequate health professionals to provide basic health care to its citizens (Central 
Board of Health (CBOH) 2003; Ministry of Health 2005b). In February 2004, the 
Mid Term Review of the Zambian NHS Strategic Plan noted that:­
<Health care is a labour intensive industry and cannot be delivered only through 
action plans, physical facilities or supplies. Without addressing this issue, we fear 
that most ifnot all of the essential indicators can be expected to deteriorate, to a 
point where the public health sector would be in danger of collapse.' (Central 
Board ofHealth (CROB) 2004) 
This observation captures the essence of the current crisis facing the health service. 
Essentially, too few staff are struggling to provide care to a population of 10.9 million 
that faces massive deficiencies in maternal and child health and rampant epidemics of 
mvIAIDS and malaria (Ministry of Finance and National Planning 2002; Central 
Board of Health (CBOH) 2003; Central Statistics Office (CSO) 2003). This has been 
exacerbated by the poor infrastructure, lack of adequate equipment, the limited 
capacity to train replacements, and poor incentives for the already over-stretched 













• 	 Chapter five presents the findings of the study. The direct costs of scaling up to 
the proposed national targets are presented in 2005 prices which are converted to 
US dollars. The costs are compared to proposed allocations in the 2006-2008 
MTEF budgets to establish feasibility of scaling up. The human resource 
requirements to scale up PMTCT are presented. based on the staff time dedicated 
to PMTCT in the selected pilot sites. 
• 	 Chapter six discusses the findings. The discussion provides further insight into the 
costs of scaling up, human resource requirements, and the assumptions used in 
this study. The chapter ends by discussing the limitations of the study. 
• 	 Finally, chapter seven gives a summary of the key findings with reference to the 
feasibility of scaling up PMTCT in Zambia. The chapter also gives 























any intervention, it is estimated that 40 per cent of babies born to HIV positive 
mothers are infected with the virus (Central Board of Health (CBOH) 2003). It is also 
estimated that HIV/AIDS morbidity and mortality results in about 50% of general 
hospital admissions (Ministry of Health 2005b). 
2.4 Political, Economic and Social Background 
2.4.1 Political Background 
After nearly a century under British colonial rule, Zambia gained independence on 
the 24th October, 1964. The United National Independence party (UNIP) lead by 
President Kenneth Kaunda assumed power in that year. The period between 1964 
and 1972 which is known as the first republic, consisted of multi-party politics until 
1972 when the constitution was changed to establish a one party rule system (World 
Health Organisation (WHO) 2002). In 1991, Zambia reverted back to multiparty 
politics and embarked on liberalization of the trade and exchange rate, parastatal 
reform, privatization of the mining sector, removal of state subsides and health 
reforms including the introduction of user fees (Lake 2000). 
, 
2.4.2 Socio-Economic Background 
Zambia is a riches to rags story. After inheriting one of the strongest African 
economies in 1964 from the British, today it is ranked as one of the Least Developed 
Countries (LDCs) in the world (Ministry of Finance and National Planning 2002). 
Zambia's economic decline can be traced to the sharp decline in prices and 
consequently production of copper, which accounts for 90% of the country's export 
earnings, support of numerous regional liberation movements and high oil prices in 
the 1970's (Central Statistics Office(CSO) 1999; Lake 2004). This reduction in 
foreign exchange earnings m¢ant that the government had less to spend on social 
sectors such as health and edtlcation (Ministry of Health(MoH) 2005). According to 
the living conditions monitoring survey of 1998, the level of overall poverty rose (that 
is those classified as moderately or extremely poor) from 24% in the 1980's to 73% 
in 1998 (Central Statistics Offlce(CSO) 1999). Gross Domestic Product (GDP) per 
Capita fell from US$ 451 in'the 1980's to US$ 359 in 2002, much lower than the 













implementing body, it has within it anumber of Technical Working Groups that play 
an advisory role to all sectorS in response to the HIV / AIDS epidemic (National 
HIV/AIDS/STDffB Council 2002). An increasing number of partners have been 
crucial in supporting the expansion of PMTCT services in 2004 and 2005 (Central 
Board of Health (CBOH) 2003). Among these are (a) the UN partners which include 
UNICEF, WHO, WFP and UNFPA, (b) the PEPFAR-funded partners such as CDC, 
JHPIEGO, MSH, CIDRZ, LINKAGES Project, SFHI, (c) bilateral agencies such as 
DANIDA, flCA, DFID and World Bank, (d) Non-governmental organizations such 
as MSF Holland, MSF Greece, PCI, DAPP, World Vision and (e) faith-based 
organizations and mission hospitals most of whom fall under Churches Health 
Association of Zambia supported by the Catholic Medical Missions Board. The 
partners are members of the PMTCT implementation team that is coordinated by the 
reproductive health unit of CBoH (Ministry of Health 2005b). Some of these partners 
provide direct financial assistance to the PMTCT program through basket funding 
while others (e.g. PEPFAR-funded partners) have vertical assistance programs that 
directly support implementing facilities with donations of drugs, testing kits, training 
of staff, equipment and infrastructure renovations. Through CBoH leadership, 
partner's activities are coordinated with an aim of streamlining delivery of PMTCT 
services in Zambia. 
2.6 Human Resources 
Human resources form the backbone of any strong health system. They are a key 
factor in enabling a health system to deliver quality health services to meet the health 
needs of any population (World Bank 2004). However, the figures in table 4 indicate 
a human resource crisis in Zambia (Kombe, Galaty et al. 2004). 











































The low numbers of annual graduates indicate the current lack of capacity of our 
training institutions to produce the numbers required to address the shortage of skills 
in the health sector. The shortages have been compounded by high attrition rates that 
have been partly as a result of the brain drain and losses of staff to mY/AIDS 
(Huddart, Furth et al. 2004). There are now growing concerns to address these 
problems, as the health system struggles to meet the demands imposed on it by the 
mY/AIDS epidemic (WorId Bank 2004). Programs such as PMTCT require added 
competencies in counseling, testing, delivery and follow up that will undoubtedly add 
to the workload of an already overstretched workforce (Huddart, Furth et al. 2004). 
This study provides a concise examination of the human resource requirements to 
meet the proposed PMTCT scale up targets. By comparing these requirements with 
the projected staff levels, conclusions and recommendations will be drawn about the 
feasibility of scaling up PMTCT. 
2.7 Description of the Zambian PMTCT Service 
2.7.1 Background 
Recognising the need to address the HIY/AIDS epidemic, the Central Board of Health 
began the national expansion process of PMTCT services to all provinces in 
December 2002 (Ministry of Health 2003). As of January 2006, there were 265 
PMTCT sites (i.e. located in district health centres) in the country across the 72 
districts and 9 provinces in Zambia out of a total of 1,327 health facilities. This 
represents 20% of all health facilities (Ministry of Health 2006). With an estimated 
550,000 deliveries every year and an estimated 19% prevalence among pregnant 
women, it is estimated that about 103,000 my infected women give birth every year 
(Central Board of Health (CBOH) 2003). In 2005, 176,184 pregnant women were 
tested and 87% of the women testing positive received nevirapine (Ministry of Health 
2005 a). Using this utilization data and the estimated 19% national antenatal my 
prevalence, approximately 33,500 of the 176,184 pregnant women were found to be 
my positive. Therefore 87% of those found to be my positive would translate to 
approximately 29,145 my positive women receiving nevirapine. From these 
calculations, it is estimated that only 29% of the estimated 103,000 my infected 















The proposed scale-up benchmarks are outlined in the table below: 
Table 5: I n 1C3tors or th a lona Id' f, e Nfl PMTCT S ca eup PIan 
Indicators 2005 
(Baseline)a 
2006 2007 2008 
IAntenatal utilizationj 97% 97% 97% 97% 
Improving VCT uptake 32% 40% 60% 70% 
~~ptance and adherence to 
V therapy 
29% 35% 50% 75% 
Follow up testing of mv 
exposed babies 
------­ 55% 70% 85% 
a Sourced form 2005 HMIS Data 
2.7.4 Main Activities 
The Zambia National PMTCT programme uses the globally agreed upon four-prong 
approach to PMTCT adopted from WHO recommendations which includes, 1) 
primary prevention of IllY among young people, women and men; 2) prevention of 
unwanted pregnancies among HIV positive women; 3) prevention of mv 
transmission from infected mothers to their babies; 4) care and support to mv 
infected families (Central Board of Health (CBOH) 2003; Family Health International 
2004). Although the four pronged approach has been advocated, it is the third 
component that involves the use of antiretroviral treatment to reduce the risk of 
transmission of mv from mother to child that has been the main focus of research 
(Sweat, O'Reilly et a1. 2004). The handling of potential clients in the pilot sites 
follows the standard national protocol (Ministry of Health 2006). The patients go 
through the following sequential steps (see Appendix I); 
2.7.4.1 Pre-test counseling 
The first step is for all pregnant women to know their serostatus using an opt-out 
approach to counseling4 • Women typically present to the antenatal clinic early in the 
morning and an initial group counseling session is given to all the pregnant women 
present. The talk is usually given by a trained midwife and includes information on 
mv infection, mv transmission, the benefits of knowing one's serostatus, 
importance of partner involvement, confidentiality of the test results, the implications 
3 CUrrent utilization of ANC already exceeds the targeted 90%, therefore the current utilization rates of 

97% have been used in this study instead. 

4 The opt-out model is a model where all antenatal care attendees receive counseling for HIV testing 













of a positive or negative test and information on Nevirapine (NVP) and PMTCT. The 
group session is then followed by individual pre-test counseling, where each woman 
is further counseled individually in private rooms by midwives. At this point women 
may either opt-out or provide consent for testing. Their antenatal books are coded to 
indicate whether they refused or accepted testing. 
2.7.4.2 mv testing 
mv testing involves the use of a screening and confirmatory test. The testing is 
conducted by trained midwives. The screening test uses a rapid test called the 
Determine test mv-1/2 from Abbot Laboratories, USA which is highly sensitive. If 
the test result is negative, then the client is determined to be mv negative, however if 
the result is positive then a second confirmatory test is conducted (see Appendix I). 
The Genie II mv-1/2 is a more specific rapid test that is used as the confirmatory test 
in Zambia. If both tests are positive then the client is confirmed to be mv positive, 
however if the first test is positive and the second test is negative the result is called 
indeterminate. A tie breaker test (which occurs in less than 1% of all cases) is 
conducted in a reference lab using an ELISA test kit (see Appendix I). The use of 
rapid test kits allows the results to be handed back to the women within one hour. 
2.7.4.3 Post- test counseling 
The post-test counseling is conducted by a trained midwife in private rooms in the 
antenatal clinic. If the client is deemed mv negative, the session reinforces how to 
maintain the mv negative status and the need to retest after 3 months as there is a 
chance that the woman could have presented in the 'window' periodS in which the 
rapid tests are unable to detect HIV antibodies. Those that test positive and agree to 
receive the results are offered the opportunity to join the PMTCT programme and are 
provided with more information on the disease and antiretroviral drugs offered. 
There are several different regimens for PMTCT that have been shown to be effective. 
The design and efficacy of some of the various drug regimens evaluated to date are 
presented in Appendix II. Due to the low cost, ease of administration and the 
5 After a person is infected with HIV, there is a period of time when s/he will not test positive for HIV but ca~ . 
infect other people. This is called the window period, and it can last from several.weeks to three ~onths. ThIs IS 












months using the ELISA test. Retesting at 18 months is conducted due to the fact that 
at 9 months a false positive result may result from a slow clearing of maternal 
antibodies to mv in the infants. In all mv exposed infants, cotrimoxazole to prevent 
Pneumocistis Carinii Pneumonia (PCP) is administered daily starting at 6 weeks until 












A 2000 UNAIDS report on costing guidelines for HIV prevention strategies explains: 
"Cost-effectiveness analyses served to provide basic evidence for on-going policy 
questions and debates. Cost analyses have always been identified with issues of 
efficiency, cost recovery and sustamability ofprogrammes. However, cost analysis 
can also play an important role in examining issues of equity and targeting which 
have recently come to the forefront of the policy debate. With the ongoing research 
and development of new HIV prevention strategies, the question of feasibility is 
integrally connected with issues of cost, efficiency and priorities for resource 
allocation. Cost and cost-effectiveness analyses are even more germane ih this 
context" (UNAIDS 2000 pg 7) 
The costing of HIV programs has come to the fore more recently following the 
establishment of the Global fund to fight AIDS, TB, and Malaria (GF ATM), "3 by 5" 
World Health Organisation initiative, the President's Emergency Plan for AIDS Relief 
(PEPFAR), and the Bill and Melinda Gates Foundation (Lake 2004). These initiatives 
are committed to scaling up health interventions and to meeting the Millennium 
Development Goals (MDGs). All these partners and key stakeholders . need 
information on costs of scalin~ up these interventions in order to buy-in to this plan, 
avoid duplication of resources, and to maximize the scale up efforts (Johns and Tan­
Torres 2005). As most of these initiatives prefer programmes that reflect national 
ownership and respect country led formulation and implementation processes, the 
availability of funding relies heavily on the preparedness and willingness of ~e 
government's health sector (Connelly 2002). It is therefore imperative that Zambia 
not only plans but also costs the planned scale up program· in order to fully take 
advantage of these initiatives. Indeed, to a large extent the succe~s o~ these .programs 
;d t'f' g and adequately funding costs associated WIth IncreasIng access 
depends on 1 en 1 ym . . ' t 
11' . trengthening prevention actiVItIes, IncreasIng access 0 
to mv testing, counse mg, ~ ..' (S"d lund Broomberg et al. 1993; 
. .; . t artlC1patlOn 0 er ,
PMTCT and increasmg comrum y P . 












study. This approach makes it easier for policy makers to understand the implications 
of scaling up a program on a limited budget (Creese and Parker 1994; UNAIDS 2000; 
Mogyorosy and Smith 2005). 
3.5 Outcome Measures 
Cost data is usually presented combined with some measure of health outcome to 
capture the expected health effects of a program (Drummond, Stoddart et al. 1987; 
Gold, Siegel et al. 1996; UNAIDS 2000). Although the costing procedures are fairly 
standard, the choice of outcome measure can differ considerably. The measures of 
health outcome can be classified into two main categories namely intermediate and 
final (UNAIDS 2000). An Intermediate outcome reflects an intermediate change in 
the intervention occurring before the final outcome. The final outcome measures the 
final impact on a health intervention (UNAIDS 2000; Dolan 2001). An example of 
the former would be the number of mv positive women accepting treatment in a 
PMTCT program and an example of the latter would be the number of infant mv 
infections averted. Evans and Hurley (1995) advocate for the use of final outcomes 
with the following argument: 
"Cost effectiveness (CE) based on intermediate outcome indicators can only be used 
to compare programmes with the goal ofproducing that outcome. Those studies based 
on final outcomes indicator can compare the efficiency of a broader range of 
programmes if they are aimed at the same outcome, such as saving lives" 
(Evans and Hurley 1995) Pg 505 
However in this study, intermediate outcomes such as antenatal mothers accepting 
VCT and number of pregnant mv positive women accepting treatment have been 
used instead of infant mv infections averted. There are several practical problems in 
determining the final outcomes of programs such as PMTCT, especially if the 
program has only recently been introduced. Although the efficacy of NVP in 
reducing vertical transmission of mv from mother to child has been established in 
several studies, the effectiveness of the intervention in the Zambian context has yet to 
be evaluated. As a result, credible epidemiological information of the actual numbers 












many analyses the assumption made was that the higher cost of transportation, 
supervision, and training in remote areas when compared to urban areas caused such 
diseconomies of scale (AIDS Campaign Team for Mrica (ACTafrica) 2001; 
Kumaranayake, Kurowski et al. 2001; Edejer 2004; Johns and Tan-Torres 2005; 
Mogyorosy and Smith 2005). In other studies there was evidence that economies of 
scale occurred when the fixed costs such as infrastructure were spread over more 
people accessing the service in urban areas (Johns and Tan-Torres 2005). Therefore 
the ideal situation would be to make adjustments to average costs based on the 
expected changes as coverage increases (Kumaranayake and Watts 2000; AIDS 
Campaign Team for Mrica (ACTafrica) 2001). However this would require one to 
re-estimate average costs as the scale of PMTCT activities increased in different 
settings, which has meant that most studies have not made adjustme ts to average 
costs but have simply multiplied the average cost of providing PMTCT services such 
as VCT, by the expected utilization of the service at the desired scale. This approach 
introduces some uncertainty around the cost estimates calculated as it is possible to 
either overestimate or underestimate the true costs of scaling up (Kumaranayake and 
Watts 2000; Johns, Baltussen et al. 2003; Evans, Edejer et al. 2005). Therefore to 
address uncertainty around the cost data a sensitivity analysis is conducted to test the 
robustness of the results within a plausible range of epidemiological and cost 
estimates (Johns, Baltussen et al. 2003; Evans, Edejer et al. 2005). 
Economies of scope occur when the cost of joint production is less than the cost of 
producing two or more related outputs separately (Clewer and Perkins 1998). The 
PMTCT program in Zambia is provided as part of an integrated reproductive health 
package which includes antenatal care, family planning, tetanus toxoid immunization, 
and anemia prophylaxis (Ministry of Health 2003). Scaling up PMTCT in an 
integrated approach may release economies of scope by using any under~utilized 
. . th h alth facilities On the other hand, if the facilities are workmg at or 
capaCIty tn e ' . . . 
. ' . f scope ( Le. increase in costs of Jomt productIOn) may
near capacIty, dIseconomIes 0 . . 
. . . 1 d d nd the intervention IS dehvered less 
be observed as faclhtles are over oa e a 












costed was not described in detail, making it difficult to assess whether the costs could 
be extrapolated to other settings in the country. In addition there was lack of detail 
regarding the identification, measurement and valuation of resources used in the 
study. There were no details given on the quantities of resources used, discount rate, 
and handling of overhead costs. The model was dependent on effectiveness data from 
other studies and made assumptions on its applicability to the South African context 
when clearly this was not the case. Furthermore the assumptions made in the study 
were not subjected to a sensitivity analysis making it difficult to assess robustness of 
the results to changes in the assumptions used. The results were prone to selection 
bias as only one rural district was sampled and extrapolated to the whole country. 
This may have overestimated the costs of the program in urban areas where there may 
be little need to improve infrastructure. 
Another study was conducted by Marseille et al (2003) to estimate the cost and public 
health impact of scaling up prevention of mother to child transmission of HIV in 
Uganda. The aim of the study was to examine the resources needed to implement this 
intervention on a national scale. The study was based on a standard micro-costing 
method at the project level and adopted a health system perspective. The model was 
based on the use of UNICEF PMTCT planning estimates of the use of nevirapine in 
Ugandan District hospitals. The model is said to cost PMTCT activities in two 
facilities, and national HIV prevalence was used to calculate the expected utilization 
for the entire country. The costing model used variable costs (e.g. test kits, drugs) and 
fixed costs (e.g. equipment, and facility improvement). The cost of providing VCT 
was calculated as US$8.28 per woman completing the counseling and testing 
sequence. The major cost driver in the VCT program was the test kit accounting for 
80% of the variable costs. The unit cost for the PMTCT program was US$289 per 
case averted or US$16 per DALY saved. The annual cost of the program was 
calculated by multiplying the unit costs by the projected numbers requiring nevirapine 
therapy nationwide. The major cost driver was the VCT program that constituted 
75% of all the costs of the program. A multivariate sensitivity analysis was conducted 
on all variables using crystal ball software package, which indicated a 90% 
probability that the program costs would be between US$2.6 million and US$6.2 












3.7 Empirical Literature 
There have been several economic evaluation studies that have been conducted to 
ascertain whether PMTCT is a technically and allocatively efficient intervention 
(Geffen 2001; Creese, Floyd et aL 2002; Scotland, Terjlingen et al. 2003; Desmond, 
Franklin et al. 2004). What is now needed is a better understanding of the costs of 
scaling up PMCT. From the literature reviewed there are a number of variations in 
the methodological approach and outcome measures used in costing and evaluating 
the scaling up of PMTCT in various contexts. These will be discussed and evaluated 
with reference to Drummond's (1996) ten point check list namely: 1) is the 
perspective explicitly stated?; 2) are appropriate costs included?; 3) are sources of 
cost data included?; 4) are quantities of resources included?; 5) are sources of 
outcome data included?; 6) is discounting used when appropriate?; 7) is marginal or 
incremental analysis used when appropriate?; 8) is sensitivity analysis used?; 9) is 
affordability of the intervention discussed?; 10) is the generalisability of the results 
discussed? 
Wilkinson et al (1999) conducted a study to estimate the cost and cost effectiveness 
nationally and for each province of a programme to reduce MTCT of HIV in South 
Africa. A model developed to estimate cost and cost effectiveness of interventions in 
Hlabisa, KwaZulu-Natal, was modified and applied to each province. This model 
assumed a 37% reduction in pediatric HIV infections if short-course oral zidovudine 
(ZDV) plus infant formula feed for 4 months were provided within a strengthened 
health system. The estimates of the number of pregnancies and HIV prevalence 
among pregnant women per province in 1997 were combined with an estimated 30% 
MTCT rate. Costs were calculated from a health system perspective, and 
effectiveness was, estimated as cost per infection averted and cost per disability­
adjusted life year (DALY) gained. The cost of a national programme was estimated at 
R155.9 million (1997 Rands, 0.94% of the annual national health budget). Major cost 
drivers were drugs (R46.4 m, 30%), staff salaries (R45.8 m, 29%), and formula feed 
(R37.1 m, 24%). The estimated national cost per infection averted was R6,724, and 
R213 per DALY gained. Provincial cost per DALY ranged from R176 to R369. 
Although the study showed that PMTCT was potentially cost-effective and affordable, 












for exchange rates and inflation rates. Uncertainty in the results was not subjected to 
any sensitivity analysis. On the other hand, one of the strengths of the study was that 
it provided an analysis of the human resource requirements to scale up the 
interventions. Health workers are central to the success of any health system (World 
Bank 1997; World Health Organisation (WHO) 2004b). The study found that the 
greatest constraint to the scale-up ofillV/AIDS services was the shortage of qualified, 
trained doctors, followed by laboratory technicians and pharmacists. The inadequacy 
of health workers in sub-Saharan Africa has been identified as a major obstacle to 
increasing access to life saving interventions to millions of people in dire need (World 
Health Organisation (WHO) 2004b; World Health Organisation (WHO) 2006). 
Desmond et al (2004) conducted a costing study of prevention of mother to child 
transmission in four sites in South Africa. The specific aims of the study included 
providing a range of cost data for informing the funding requirements of a national 
roll out of the PMTCT program and cost data that could be used for policy, planning 
and management. Two rural and two urban sites were purposively selected in order to 
capture a range of costs associated with differences in resources and HIV prevalence 
at the sites. The costing approach used was designed to capture economic costs of 
providing the intervention, defined as the financial cost of the resources that were paid 
for directly out of the PMTCT budget as well as the value of existing resources (e.g. 
existing staff). The perspective used was the provider's perspective and patient costs 
(e.g. cost and time borne by patients to access VCT and free formula) were excluded 
from the analysis. The input categories that were captured were facilities 
(infrastructure), staff, drugs (nevirapine, cotrimoxazole etc), infant formula feed and 
others (e.g. test kits, training). To enable comparison between the different sites, the 
PMTCT program was broken down into five components namely pre-test counseling, 
testing, post-test counseling, delivery, and follow up care. The inputs were costed in 
each category. The training costs and capital infrastructure were annualized over 5 
and 15 years respectively. Compared to the other components, in one of the sites, the 
total costs of the pre-test and post-test counseling components included a high 
proportion of direct [mancial costs (71% and 76% respectively). This occurred 
primarily as a result of the appointment of lay counselors. Staffing was found to the 












accounted for 17% of the total costs. There was great variation in administration and 
startup costs in the various sites due to different staffing levels. The areas with higher 
prevalence were found to have higher total costs, but lower unit costs. The results 
have to be interpreted with caution due to a number of limitations. Although 
infrastructure and other capital investments were annualized, there is no mention of 
the discount rate used and no sensitivity analysis was conducted. The presentation of 
results lacked transparency on the handling and allocation of overhead costs. These 
limitations make it difficult to asses the relevance and generalisability of the results. 
There is very limited cost data on PMTCT in Zambia. Mwikisa (2002) conducted a 
study to determine the financial implications of HlV/AIDS interventions in Zambia. 
The costing approach varied for the different components of the HlV/AIDS 
interventions. International standard cost estimates from neighboring counties, cost 
estimates from other studies, and expert opinion was used for PMTCT. The model 
uses assumed coverage targets of 10,000 pregnant women screened in 2001; 100,000 
in 2002; and 250,000 in 2003. It was assumed that 30% of women would be expected 
to test positive of which 70% would go ahead with treatment. Of these it was further 
assumed that 50% would be treated with short course AZT and the 50% with 
Nevirapine. Using a UNAIDS costs estimate it was assumed that the cost for one 
woman managed under short course AZT is US$130 and Nevirapine is US$84. In 
addition the model assumes an expansion cost of US$500,000 for each 10,000 new 
clients plus 10% of running costs to cover strengthening of antenatal clinic. Using 
these assumptions it was estimated that a total cost for 2001-2003 of US$27.3 million 
would be used for PMTCT of which US$18.8 million would be attributed to 
expansion costs and US$8.5 million would be for running costs. It was noted the 
entire cost was to be borne by donor partners as nothing had been committed by the 
Zambian Government. Similar to a number of other studies, this study relied on 
assumptions and hypothetical costs from unkilown sources, international 
organizations, and other developing countries to estimate the costs of a national 
PMTCT program. These assumptions may not be generalisable as health system 
practices vary greatly from country to country. Furthermore the assumptions were not 
subjected to any sensitivity analysis. Precision and accuracy should have been of 












implementation! The perspective used in this study was not stated making it difficult 
to identify which costs were included in the study. There was also very little 
transparency in identifying health resources used, handling of capital costs, allocation 
of overheads, adjusting for inflation and differential timing of costs. This greatly 
compromised the validity of the results. 
Stringer et al (2003) used a crude measure of Zambia's PMTCT program costs that 
did not take into consideration Drummond's recommended guidelines in conducting 
a cost analysis. Even more disconcerting is a lack of any detail on the methodology 
used to come up with the final estimates. The calculated unit costs were US$9.34 per 
patient counseled, US$12.96 per patient tested, and US$SS.12 per seropositive woman 
identified or US$848.26 per infection averted. The study concluded that prevention 
of mother-to-child mv transmission was feasible and cost-effective in resource­
limited settings. However, the perspective of the study was not revealed, a 
description of the alternative interventions was not given, costs and health benefits 
were not identified and valued credibly and the study did not take into consideration 
any discount rate or sensitivity analysis. An intervention is only said to be more cost­
effective if it is less costly and more effective than its comparator. In a situation 
where an intervention is more costly and more effective, an incremental cost­
effectiveness ratio gives a clearer indication of the additional costs required for the 
additional benefit and is therefore a better policy guide. However in this study the 
total costs, effectiveness of the alternative interventions, and an incremental analysis 
were all omitted. Furthermore there was no examination of the budgetary 
implications of such findings. Such discrepancies were unlikely to positively affect 
an astute policymaker. The lack of a full costing exercise on the PMTCT program in 
Zambia has left a lot of gaps in information for planners and policy makers. 
A study by Galbraith and Bennish (2001) aimed to estimate the incremental costs of a 
program to reduce MTCT of mv in Hlabisa, a rural district of South Africa The 
major components of the program consisted of management, community mobilization, 
VCT, Nevirapine intervention, and follow up. A costing model that only included 
incremental costs was developed. It excluded preexisting district resources (e.g. staff 












national PMTCT program. The model uses an assumed lifespan of 32 to 60 months 
and monthly grants of 100 Rands to calculate the welfare costs for a mv positive 
child. In the interventions assessed, it was assumed that 90% to 93% of pregnant 
women would consent to an mv test and that 92.5% of these would accept treatment 
with ARVs. By reviewing several studies, the perinatal transmission rate among HIV 
positive mothers who breastfeed and accept AZT was assumed to be 16.5% to 18%, 
while among those accepting NVP the transmission rate of 13.1% was used. The 
transmission rate among those mv positive mothers not using any ARVs was 
assumed to be 25% to 31.6%. The results were presented with the best case and 
worse case scenarios. The total direct costs of an AZT intervention were between 
US$12.6 and US$22 million. VCT (pretest counseling, testing, post-test counseling) 
accounted for 35% to 58.7% of these costs while providing AZT and PCP prophylaxis 
accounted for 41.2% to 65% of these costs. Nevirapine with a direct cost­
effectiveness ratio of US$195 to US$410 per child saved was found to save more 
lives and was more cost-effective than using AZT that had a cost-effectiveness ratio 
of US$688 to US$916 per child saved. The authors show that the costs to government 
of health and welfare expenses for HIV positive children are greater than the costs to 
government of implementing a PMTCT program. The authors consequently argued 
that the PMTCT programs were clearly affordable. This study was not without 
limitations. In this study the perspective was not explicitly stated making it difficult 
to ascertain whether the full range of relevant costs were included. The inclusion of 
welfare grants for mv positive children was highly controversial as these transfer 
costs simply represent transfer of resources from one party to another and do not 
strictly represent a real economic cost in resource use. Despite the inclusion of these 
future welfare costs, no discounting was conducted which biased the results towards 
greater savings resulting from implementation of a PMTCT program. Another 
interesting finding of the study was that the total health and welfare costs of the AZT 
and NVP interventions were significantly more than the costs that would be saved if a 
program was implemented compared to doing nothing. The high costs of both 
interventions negated any potential saving arising from their implementation. In 
conclusion the authors advocate for the implementation of the more effective PMTCT 













3.7.1 Implications for This Study 
Many of the studies reviewed revealed great variation in methodological approach, 
sources of cost data, outcome measures used and some lacked sufficient details about 
the services being costed, inclusion and exclusion of costs, discount rate, the handling 
of overheads and sensitivity analysis. Clearly, no one study can answer all the cost­
related questions in a PMTCT or IllV/AIDS program. There will always be 
limitations based on the context of the study, assumptions used, availability of cost 
and outcome data, and the methodological approach used. In addition, there are 
several disagreements in literature on the recommended perspective of study, costs to 
exclude or include, approach to valuing opportunity costs, handling of overhead costs, 
measurement and valuation of indirect costs, choice of outcome measures and choice 
of discount rate, which all lead to great variation in the costing methods used. 
Therefore it becomes more important that one is as transparent as possible on the 
decision problem, the methodological approach used and model assumptions to allow 
the reader to assess for themselves the relevance of the results to their own settings. 
This study uses the consensus in literature on defining a decision problem, describing 
the service, followed by identifying, measuring and valuing resources and conducting 
a sensitivity analysis to establish costs ass ciated with scaling up PMTCT in Zambia 
This study provides real costs from two existing pilot sites that will aid decision 
makers to make real trade offs between costs of scaling up and the practical 
constraints of scaling up. The provider's perspective was used in order to establish 
the direct costs that will be borne by government and donor agencies in implementing 
a scale up program. Although some advocate for a societal perspective, a provider's 
perspective will aid policy makers to better understand the budgetary and financial 
implications of the program. Intermediate outcomes as opposed to final outcomes are 
used as credible epidemiological data on the number of IllV infections prevented by 
PMTCT is at present lacking. The use of intermediate outcomes will also allow a 
comparison of the costs of the different components of the PMTCT program with 
. other studies that have presented the results in the same way. In addition, showing the 
costs of a combination of activities would help planners to strategize on what 
combination and volume of each activity they would want to scale up to best meet 












incremental approach. This method allows all the economic costs, both existing and 
new, to be taken into account including infrastructure and overheads, thus avoiding 
underestimating costs of displaced resources, required extra space, and administration. 
Average or unit costs that include both fixed and variable costs are used instead of 
marginal costs, which exclude fixed costs. The use of unit costs allows 
generalisability to national levels, when changes to infrastructure are expected as is 
the case in a PMTCT program. In contrast to some studies that use cost estimates 
from international organizations, other studies and other developing countries, this 
study makes use of actual data from interviews with local experts and facility staff, 
the central statistical office, local routine facility based information together with 













3.7.2 Conceptual Framework 
Based on literature (Wilkinson, Floyd et al. 1999; Kumaranayake, Kurowski et al. 
2001; Scotland, TerjIingen et al. 2003; Kombe, Galaty et aI. 2005) there are several 
factors that one must consider before scaling up a program. Figure 2 below depicts a 
framework for analyzing these factors. 
Demographic Data 
(e.g. Population size, fe
rate, pregnant mothers) 
rtility 
Epidemiological Data (e.g. 




1 1 1 
Baseline Scenario (PMTCT) I I 

1 
Utilization of Service (e.g. ANC Resources used (e.g. Personnel, 
coverage, vcr uptake rate, adherence to antiretroviral drugs, HIV test kits, 
PMTcr antiretroviral protocol) building space, etc) 
Targeted scaled up coverage 
(e.g. increasing ANC coverage, Specific Unit Costs (e.g. cost per vcr 
vcr uptake, adherence to episode, costs per delivery) 
ARVs) 
Additional Resources Required 
(e.g. personnel, drugs, test kits building 
space etc) 
Scaled Up Scenario (PMTCT) I I 

I Budgetary Implications 
I 
Figure 2: Conceptual framework 
The conceptual framework, as illustrated in Figure 3, looks at two main scenarios; the 
current or baseline and the desired or scaled-up one. In the baseline scenario, the 
epidemiological and demographic data (see appendix III) describe the current users of 












greatly dependent on the number of pregnant women, the overall HIV prevalence rate 
and the scale at which the service is offered. The resources used in the facilities 
essentially define the total cost on items such as staff salaries, training, drugs, test kits, 
infrastructure and equipment costs. By combining the utilization data for services 
used (pre-test counseling, delivery, testing and post-test counseling) and the total cost, 
the unit cost per service can be estimated. The functional scale up must go hand in 
hand with organizational scale up. Functional scale up implies an increase in both the 
number and type of activities to be performed. For example there will be an increase 
in the number of pregnant women accessing VCT in addition to the introduction of 
new antiretroviral treatment regimens for consenting mv positive mothers. 
Organizational scale up implies an increase in capacity at international, national, 
provincial, district and community to support district expansion, interaction linkages, 
monitoring and evaluation, and co-ordination (Ministry of Health 2005b). In light of 
this, the level of commitment from the national level and health facilities must be well 
coordinated and focused. A focused analysis of the allocations to the health budget 
may provide clues to this commitment. 
The scaled-up scenario embodies choices that were made by policy makers. In 
Zambia, the targets that were set following the UNGASS meeting of 2001 included 
increasing utilization of ANC services to 90% of all pregnant mothers, 70% VCT 
uptake by expectant mothers and 75% adherence to treatment of those found to be 
mv positive by 2007 (UNAIDS 2003b). These assumptions have direct implications 
for the number of clients to be seen, and the resources needed to provide the service. 
Once the baseline information is entered the total estimates for costs and resource 
requirements in the scaled-up scenario can be calculated. The total costs for the 
scaled-up service is equal to the baseline unit cost multiplied by the number of people 
who are targeted to receive it in the scaled up scenario. The human resource 
requirements per annum can be calculated from the full time equivalent (FTE), which 
is derived by dividing the actual total hours that staff devote to the PMTCT service by 
the average number of working hours per annum for clinical staff in the public sector. 
Therefore, by calculating the expected gap in utilization for these services between 
baseline and scaled up scenarios the costs and resources needed for the scaled-up 












the Ministry of Health in 2006 and 2007, the number of mothers that can be treated 
each year can also be calculated. Using different assumptions for the growth of the 
PMTCT budget, this study illustrates the different consequences of increased 
population coverage. This framework helps in thinking through and conceptualizing 
requirements for scale up such as human resources, infrastructure, test kits, and drugs. 
However, the framework is not intended to measure the cost-effectiveness of 
alternative regimes, nor is it meant to project the AIDS epidemic. This is best done 












CHAPTER 4: METHODOLOGY 

4.0 Introduction 
This chapter outlines the field work methodology that was used in this study. The 
sources and types of data collected are discussed and examined. A detailed discussion 
of the costing methodology is presented. The chapter also discusses the data 
collection and sampling techniques employed as well as the method of data analysis 
used. The chapter ends with a brief description of the ethical issues involved in the 
study. 
4.1 Study Design 
This was a descriptive study that used a retrospective ingredients approach in 
identifying, measuring, and valuing resource use in the selected pilot sites. The study 
focuses on resources used in the Zambian public sector in scaling up PMTCT from a 
provider's perspective. In order to increase relevance of the study findings a full cost 
analysis as opposed to an incremental approach was used to calculate the average cost 
per service provided (e.g. cost per mother tested) in the selected pilot sites. Full 
costing as opposed to an incremental approach involves calculating all relevant costs 
of producing a PMTCT service and therefore includes the opportunity costs of 
existing resources (e.g. infrastructure, staff time) that may be displaced as a result of 
the program. In order to gain a clear and detailed description of the PMTCT scale up 
process and targets, the study incorporated the use of qualitative and quantitative data 
from key informants in the Ministry of Health, PMTCT implementation team, site 
staff and the Central Board of Health. Apart from the total costs, the feasibility of 
scaling up is explored by examining issues such as human resource requirements and 
affordability within the proposed 2006-2008 MTEF expenditure estimates. 
4.2 Study Sites 
The study was conducted mainly in two parts as data were collected at two levels, 
namely at central level and at pilot site level in Zambia. The process of data 
collection used a combination of key informant interviews and in-depth reviews of 
records, documents, national statistics and unpublished literature. Data collection at 
central level involved baseline information on the PMTCT process including 












targets for scaling up PMTCT, the 2006-2008 MTEF expenditure estimates, the 
number of facilities offering PMTCT, and national human resource data. This data 
was extracted from Ministry of Health (MoH) and Central Board of Health data bases 
such as Health Management Information Systems (HMIS), Financial and 
Administrative Management System (FAMS), and document reviews of the Health 
Sector Committee basket reports, Annual Health Statistical bulletin, Demographic and 
Health Survey reports, Local Conditions Monitoring Survey reports, Human 
Resources Strategic Plan, and the PMTCT strategic plan. Data collection was 
conducted in a collaborative fashion in which key informants assisted in collecting 
relevant information. The use of such a method was aimed at increasing the relevance 
of the results to key stakeholders. 
In order to gain a deeper insight into the objectives, goals, coordination, policy, 
resource mobilization, and current constraints in the scale up process key informants 
were purposively selected for a semi-structured interview (see Appendix IV) from the 
Ministry of Health, PMTCT implementation team, and Central board of Health. Key 
informants were selected for the semi-structured interviews based on their expertise 
on PMTCT and availability during the data collection period. After an appointment 
was made with the informant, the interviews were conducted on the agreed date in an 
isolated environment to enable the respondent to express themselves freely without 
any interference. In addition this enabled the respondents to explain in detail their 
understanding of scaling up, objectives, goals, coordination, policy, resource 
mobilization, and current constraints in the scale up process. The selected key 
informants included seven members of the PMTCT implementation team, four from 
collaborating donor partners, and two from the CBoH and MoH. This was done in 
Lusaka, which is the capital city of Zambia where both Central Board of Health 
(CBoH) and Ministry of Health (MoH) are located. Hence, there was no sampling 
required at this stage. The second part of the study involved the costing of the 
PMTCT program in selected pilot sites. Unfortunately due to limited resources and 
time, the study could not cover a large number of facilities. Two pilot sites were 
selected by random stratified sampling from the sampling frame that contained the 
262 available pilot sites. The sites were stratified by geographical setting i.e. rural 












random numbers table, one site was randomly selected from each stratum i.e. one site 
from a rural setting while the other was from an urban setting. This was done in order 
to capture possible variation in costs due to differences in geographic setting, mv 
prevalence, equipment use, infrastructure, and drop out rates. There was a difference 
in the maturation of the PMTCT program with the urban and rural site program 
having been in operation since 2002 and 2003 respectively. 
4.3 Costing Approach 
The approach to costing the scaled up PMTCT activities is based on a standard micro­
costing method at the health centre and client level, adopting a health care system 
(provider's) perspective. The costs borne by patients and households such as time lost 
from work, travel time, waiting ti)ne, user fees and transport fares are therefore not 
included in this analysis. The use of micro-costing assumes that the mix of inputs can 
be generalized to the next application in a new setting (Johns, Baltussen et at. 2003; 
Evans, Edejer et al. 2005). This assumption is critical in costing a scale up program, 
as the feasibility of the scale up program will depend on the ability to replicate the 
pilot program in other areas (Evans, Edejer et al. 2005). In each of the selected 
facilities the site manager (a doctor), the PMTCT coordinator (usually a midwife), and 
3 other midwives involved in PMTCT were interviewed. The interviews with the 
mentioned staff provided information on the description of the PMTCT program, 
resources used and current constraints in running the program. Using this bottom up 
approach, the quantities for each item used are established, multiplied by the cost of 
each item, summed and then divided by the unit of outcome to calculate unit costs 
(e.g. cost per mother counseled, cost per mother tested, cost per mother and child pair 
adhering to treatment). The model used in this study assumes the scale up of PMTCT 
according to the mVNET 012 protocol being implemented in the selected pilot sites. 
Information on the composition, activities, inputs, process and outputs of the PMTCT 
program was obtained through a series of staff semi-structured interviews (see 
Appendix IV and V) as well as in-depth reviews of facility HMIS, F AMS reports, 
asset registers, laboratory and pharmacy records, staff establishments, and annual 
district plans. The use of the semi-structured interviews held with key informants in 
the selected facilities was used to obtain a detailed description of the service provided, 
staff involved, facilities used, drug regimen and test kits used. This process helped to 












description included an identification of the resources used at each stage (and 
comment if they were any different from what should have been used based on the 
national protocol), time spent on providing each service, space allocated and 
comments on the current constraints in providing PMTCT services. 
4.4 Categorization and Allocation of Costs 
Over a period spanning from December 2005 to February 2006, all the relevant 
recurrent and capital costs associated with the PMTCT program from January to 
December 2005 were collected (see Appendix VIII and IX). These costs were further 
classified according to those associated with pre-test counseling, testing, post-test 
counseling, delivery and follow up. This allows one to identify which of the 
processes are the essential cost drivers and allows us to compare the results with other 
studies that have used similar methods. The recurrent costs, which are resources that 
are consumed within a year of purchase, included: salaries of staff, drugs (NVP pills 
and suspension, cotrimoxazole syrup), HIV test kits (Determine Abbot and Genie II), 
transportation (travel allowances for staff, fuel costs, oil charges), maintenance costs 
(building, vehicles, equipment), stationary, utilities (telephone, electricity, water), 
and other supplies (test tubes, 5mls syringes, examination latex gloves, 21g needles, 
750 ml bleach solution, methylated spirit, waste containers, biohazard bags). The 
capital costs, which are resources that have a useful life span of greater than one year, 
included: vehicles (motor bikes, 4 x 4 automobile), equipment (electric or manual 
centrifuge, rotator, timers, thermometers, automatic pipette, electric or kerosene 
refrigerator, sphygmomanometers, weighing scales, delivery kits (including draw 
sheets and aprons), furniture (counseling room tables, chairs, and cupboards; delivery 
and examination beds), non-recurrent training, and other capital costs (e.g. computers, 
radio, televisions and printers). In valuing resource use both available financial and 
economic costs were estimated in this study. The financial costs refer to the actual 
expenditure on goods and services used in the study while the economic costs are the 
opportunity costs associated with items in the program. This takes into account the 
costs of existing facilities and the productivity costs to staff due to displacements from 












Salary costs were calculated as gross (i.e. pre-tax) salary and contribution to pensions 
plus other benefits were taken into account. These costs were estimated from salary 
records kept by the hospital administrator and by interviewing relevant staff. They 
were confirmed by comparing these figures with official pay scales at the Ministry of 
Health. The productivity time of staff was calculated as the proportion of their 
salaries that could be accounted for by the proportion of total working hours spent 
providing the service. Interviews can be subjective depending on who is being 
interviewed and what opinion they may have. Therefore in order to verify the time 
spent on providing different activities, time and motion studies were conducted to 
directly assess time spent on pre-test counseling, testing, post-test counseling, delivery 
and follow up. This is a more accurate method as personnel may either underestimate 
or overestimate the time spent on various activities. A total of a least five 
observations of each service was conducted in each facility and an average time 
required for each service was then calculated in each of the selected facilities. 
Most of the drugs, HIV testing kits and supplies that were found at the sites were 
either donated by partner organizations or centrally procured by the Ministry of 
Health. The quantity of drugs, HIV testing kits and medical supplies used was 
extracted retrospectively by examining pharmacy and laboratory records which were 
coded for the PMTCT service. The value of drugs, HIV testing kits and the other 
medical supplies was obtained from the Ministry of Health procurement unit using 
existing market prices of procured supplies. These prices included a 25% markup 
which was added for the costs of insurance, freight, import duties, storage and 
distribution. The total costs of drugs, HIV test kits and supplies were estimated by 
mUltiplying the quantity used between January and December 2005 by the relevant 
price for each. These costs were all (100%) allocated to the PMTCT program (see 
Appendix VIII and IX). 
Maintenance, transport, stationary and utilities costs were obtained by retrospectively 
reviewing facility F AMS data for the period spanning from January to December 
2005. These overhead costs were directly allocated to the PMTCT program based on 
an allocation factor that was worked out as a proportion of the total annual visits that 












infrastructure used in PMTCT activity including drug storage was conducted and 
dimensions of the facilities were collected from building records kept by the hospital 
administrator. Vehicle costs were directly allocated to the PMTCT program 
according to the percentage of total mileage which involved PMTCT activity. 
Information on the actual mileage associated with PMTCT was obtained from F AMS 
records and the transport register of each vehicle which contains detailed information 
on the dates, destination, distance and a brief explanation on the reason for the trip. 
Capital costs which included buildings, vehicles, equipment, furniture, non-recurrent 
training, computers and printers were valued based on current replacement value, and 
then annualized using an assumed discount rate of 3% and assumed useful life to 
obtain an equivalent annual cost (see Appendix VIII and IX). This method 
automatically incorporates both the depreciation aspect and the opportunity cost 
aspect of the capital costs (Brouwer, Rutten et al. 2001). The replacement values of 
building spaces allocated to PMTCT was estimated using the 2005 market prices of 
building per meter squared of space as information on the full building costs was 
absent. The replacement values and useful lifespan for buildings, vehicles, 
equipment, training, furniture and other capital costs was obtained by consulting the 
appropriate experts at the Central Board of Health and Ministry of Health. The 
equivalent annual costs were calculated assuming a useful lifespan of 20 years for 
buildings, 10 years for equipment, furniture and vehicles and 5 years for training, 
computers, televisions and radios. The costs associated with training were regarded 
as a capital cost as the skills accrued from training are beneficial over many years and 
hence cannot be burdened on the current financial year. The total training costs 
included the 1 week orientation costs of the district health management team 
(DHMT), community mobilization costs, and the in-service training costs for clinical 
staff and site manager. In-service training consisted of a 4 week training program that 













All values are shown in the 2005 US Dollars using an exchange rate of 
ZMK6 3, 600 =1 US$, which was sourced online from http://www.xe.comlucc(xe.com. 
the universal currency converter) in November, 2005. The effect of a fluctuating 
exchange rate was examined in the sensitivity analysis. The values used in the 
sensitivity analysis were based on actual exchange rates from January 2004 to 
December, 2005 and were obtained from the central statistical office. The most recent 
cost data for each health facility were for the 2004/2005 financial year. As some of 
the cost data were for 2004 the only way of comparing the cost data for the same 
period was to adjust the prices to 2005 prices by using the consumer price index. In 
this study 2004 ZMK prices were adjusted to 2005 ZMK prices by using an inflation 
rate of 18.2% which was extracted online from http://www.zamstats.gov.WJ ,which is the 
official Zambian Central Statistical office web site (Central Statistics Office 2005). 
The total costs for each element of the service were calculated by first allocating each 
resource to each element and then summing up all the recurrent and capital costs. 
Output measures were extracted from reviewing client utilization data in each facility 
over the same corresponding period i.e. January to December 2005. From this data, 
the number of pregnant women using ANC, the number of pregnant women offered 
VCT, number of pregnant women undergoing testing, the number of pregnant women 
found positive, number of HIV positive women who accept ARV treatment according 
to the HIVNET 012 protocol, the number of HIV positive women who adhere to the 
treatment and the number of mother and baby sets that adhere to follow up testing was 
collected. 
The unit costs were then calculated by dividing the total costs of a particular element 
of the service with the corresponding output units. Hence the cost per mother pre-test 
counseled, cost per mother tested, cost per mother post-test counseled, cost per 
delivery (i.e. mother and baby adhering to ARV protocol) and the cost per mother and 
baby set that adhere to follow up testing can be calculated. 











resource use, epidemiology of the disease and need to invest in infrastructure 
improvements. The use of analytical methods in the measuring and valuing of 
resources such as the choice of discount rate and choice of exchange rate introduce a 
degree of uncertainty in the results. The standard practice is to handle uncertainty by 
conducting some form of sensitivity analysis. To test the robustness of the results a 
simple sensitivity analysis (one-way and multi-way) was conducted in this study. A 
simple sensitivity analysis is used to test the generalisability of the results and to 
analyze uncertainty related to analytical methods (Briggs 1995). A number of key 
variables such as the cost of drugs and mv test kits, discount rate, exchange rate, 
antenatal population, mv prevalence, staff time, and uptake rates were varied in 
plausible ranges in order to test how sensitive the model design was to these variables. 
The effect of distributing the input values between a low and high case country level 
scenario on the calculated baseline total costs of the scaled up PMTCT program was 
examined in the one way analysis. The effect of combining all the input values in the 
low and high case scenarios on the calculated baseline total costs of PMTCT was 
examined in the multi-way analysis. The range of plausible drug and mv test kit 
costs were obtained from the Ministry of Health and were based on the 2005 quoted 
market prices of various suppliers of originator and generic supplies. The low case 
scenario was associated with cheaper generic supplies while the more expensive 
originator supplies were used in the high case scenario. The range of values used for 
examining the uncertainty around the antenatal population, HIV prevalence, exchange 
rate and VCT uptake rates were obtained from the central statistical office in Lusaka. 
4.5.2 Human Resource Requirements 
In order to calculate the human resource requirements, methods used by Kombe 
(2005) were adopted in this study. The human resources requirements are calculated 
from the full time equivalent (FfE), which is derived by dividing the total annual 
workforce hours required for PMTCT services by the total annual number of hours 
that staff devotes to providing client services. Therefore based on the expected annual 
utilization of services (pre-test counseling, testing, post-test counseling, delivery and 
follow up) and associated required time per service, the total time required annually 
can be calculated. Based on information obtained from the facilities, health workers 
have an average of 36 days annual vacation, 20 days sickness leave, 12 public 












average number of working days is 180. Staff work for 8 hours per day of which 6 
hours are devoted to providing all client services including PMTCT while the other 2 
hours are spent in meetings, workshops, recording information, and waiting time. 
Therefore the total annual number of hours that staff devotes to client services is 
assumed to be 1,080 hours. By calculating the total number of personnel required the 
associated training costs and required salaries were then calculated. The required 
staffing levels to scale up to the 2008 coverage targets are compared to the projected 
numbers that will be available at current attrition and entry rates in the health sector in 
2008. 
4.6 Data Sources and Collection Methods 
The data collection period was 3 months from December 2005 to February 2006. In 
line with the objectives set out for this study, table 7 below outlines the specific data 
to be collected, method of collection and the source of the information. 
.T ble 7 Ob' nectlves, spec. IC data to e coIIecte d h d suseda . 'fi b d an met o 
Objective Specific data to be collected Method of collection and source of 
infonnation 
i Number of pregnant women using ANC, Review of facility HMIS utilization 
vcr services, testing positive and data (January-December 2005) 
adhering to treatment and follow up 
i PMTcr service provided, resources Interview with site staff (see 
I used, number and type of cadre Appendix V), review of staff 
providing PMTcr service establishments 
Time dedicated to each service Time and motion studies 
To estimate the average direct 
health care cost per mother 
attended to for vcr services, 
delivery, and follow up in the 
pilot study sites from a 
provider's perspective. 
Staff salaries 
Other service costs (recurrent and capital 
costs) 
Interview with site staff and review of 
official pay scales at the Ministry of 
Health 
Interview with key staff, review of 
Financial Administration 
Management records (F AMS) 
(January-December 2005), expert 
opinion from CBoH 
Quantity of drugs, test kits and supplies Facility utilization data (January­
used December 2005), review of 
laboratory and pharmacy records 
Dimensions of space used for PMTCT in Physical inspection and 
the facility measurements 
Training costs, duration, content, and with staff, review ofFAMS 
source of funding central and facility level 
To estimate the direct costs Demographic and epidemiological data Central statistical office website; 
associated with scaling up (see Appendix III) review of Zambia Demographic 
PMTcr services to the required Health Survey, 2001- 2002; Health 
national targets from a Management Information Systems 
provider's perspective. (HMIS), sentinel surveillance reports, 
Central Board of Health and Ministry 
of Health data bases 
National PMTCT targets Central Board of Health, 2003 













Total number of facilities and the 
number offering VCT and PMTCT 
services 
Central Board of Health, Health 
Management Information Systems 
(HMIS) and review of annual statistic 
bulletin 
Current number of counselors/midwifes Ministry of Health, department of 
planning; review of the human 
resources strategic plan 
To calculate the proportion of 
the national health budget that 
will be needed to scale up 
services to all 72 districts.' 
Projected 2006-2008 MTEF health 
sector budget 
Ministry of Health and Central Board 
of Health Planning Units 
To describe organizational and 
management of PMTCT in the 
study pilot sites 
Qualitative data from site manager, key 
informants and National PMTCT 
coordinator on coordination of process 
and lessons learnt so far 
Semi-structured key informant 
Interview (see Appendix IV and V) 
To describe current human Time dedicated to each service Time and motion studies 
resources used and provide 
estimates for workforce 
PMTCT service provided, Number and 
type of cadre providing PMTCT service 
Interview with site staff 
(see Appendix V) 
required to scale up PMTCf Current Number of Central Board of Health, Health 
services. CounselorslMidwives Management Information Systems 
(HMIS), review of the Human 
Resource plan 
In this study both qualitative and quantitative data were used. All quantitative data 
such as cost data were analyzed in Microsoft Excel® while qualitative data such as 
description of the PMTCT service were analyzed in Microsoft word®. 
4.7 Quality Control 
The methods used to increase reliability and validity (internal and external) in this 
study included: 
• 	 Semi-structured interview schedules were piloted on 15 people and redrafted 
twice before carrying out the study to ensure that the questions would be clear, 
simple and unambiguous to the respondents. 
• 	 During the interviews, the initial questions were followed up by probing questions 
to ensure that the initial information that was offered was correct. 
• 	 The interview schedules were designed deliberately to ask two or more similar 
questions that would yield similar answers. This was done to increase reliability of 
the response obtained. 
• 	 Where possible, an attempt was made to re-interview the key informants on a 
selected proportion of questions. Responses from the first interview and the 













• 	 When differences or inconsistencies were found, the more accurate methods of 
reviewing records, documents, databases and observational techniques (time and 
motion studies) were used to verify the responses given in the interview. 
4.8 Ethics 
The collection of information relied on conducting interviews with key informants, 
reviewing documents, facility records, observation and did not review any patient's 
record nor did it involve interviewing any patients. Ethical clearance to conduct the 
study was granted by the Research Ethics Committee of the University of Cape Town 
(see Appendix VI). In addition authorization was also granted by the Zambian 
Ministry of Health to conduct the study. In each of the selected facilities, the purpose 
of the study was explained and participants were assured that any information that 
was offered during the study would remain anonymous and no record of the facilities 
or any information that would link them to the study would be made public. 
Therefore in this study the sites are simply referred to as urban site and rural site. 
Each of the key informants that was asked to participate was informed of their right to 
decline participation and to withdraw from the study at any given time. The proposed 
benefits of the study were explained to the participants and each of the participants 
and stakeholders was given the assurance that they would receive a copy of the final 
report. Informed consent was then sought from all participants by signing a consent 












CHAPTER 5: RESULTS 

5.0 Introduction 
This chapter presents the findings of the study. Section 5.1 provides a brief 
description of the staffing levels and services provided in each of the study sites. 
Section 5.2 takes a detailed look at PMTCT utilization data from each of the facilities. 
The direct cost of providing PMTCT in each facility is presented in section 5.3. 
Section 5.4 shows the costs categorized by PMTCT component (i.e. pre-test 
counseling, testing, post-test counseling, delivery and follow up). The unit costs are 
estimated in section 5.5 and the costs of scaling up the PMTCT program to the 
proposed national targets are estimated in section 5.6. A sensitivity analysis is 
conducted to test the robustness costing model in section 5.6. The chapter ends by 
examining the human resource requirements in section 5.8. 
5.1 Service Provision in the Study Sites 
The urban health centre provides services to an estimated catchment population of 
310,000 in a rapidly growing peri-urban area while the rural health centre provides 
services to a much smaller and less densely populated area with a catchment 
population of 121,000. PMTCT services in Zambia are provided through health 
centers and day hospitals as part of an Integrated Reproductive Health program which 
includes antenatal care, postnatal care, family planning, and training of traditional 
birth attendants. The centers also provide other basic curative, preventive, obstetric, 
nutrition and child health services. The selected health centers for this study operate 
for a total of 8 hours during the weekdays during which time antenatal bookings and 
follow up visits are made. Table 8 below provides a breakdown of staff working in 
the health centers. The midwives are responsible for the provision of PMTCT 












:'ype and numbT bl a e 8 T er 0 f staff working In the se ecte d h ea t I h centers 
Staff Category Urban Health Centre Rural Health Centre 
Registered Midwife 4 -­
Enrolled Midwife 2 3 
Registered Nurse 4 1 
Enrolled Nurse 13 7 
Nursing officer in charge 1 1 
Medical Officer 2 1 
Driver 1 2 
Dental Technician 2 1 
Radiographer 2 1 
Clerk 5 2 
Cleaner 14 8 
Hospital administrator 1 1 
Environmental technician 2 1 
The urban facility has a total of 6 midwives of whom 4 are registered and 2 are 
enrolled. In comparison the rural facility has no registered midwives and 3 enrolled 
midwives. Registered midwives have more training and experience than enrolled 
midwives. Therefore, the urban facility has both a greater quantity and caliber of staff 
than the rural facility. An examination of the other staff groups reveals a similar 
staffing pattern which is skewed in favour of the urban centre. 
5.2 Utilization Data for the Selected Health Facilities 
Table 9 provides 2005 annual utilization data for the clinics. 
Table 9: 2005 annual utilization data for the Health centers 
Clinic Total Visits 
PMTCT Associated Visits· 
(%) 
Urban 22,897 5,544 (24%) 
Rural 10,821 1,599 (14%) 
"'Visits assocIated WIth ANC and vcr (pre-test counsehng, testmg, post-test counselIng) were counted 
as one visit as they were offered as part of an integrated package, while visits associated with delivery 
and follow up were counted separately. 
The number of visits in 2005 was 22,897 in the urban health centre and 10,821 in the 
rural health centre. The total number of PMTCT associated visits was 5,544, or 24% 
in the urban health centre and 1,599 or 14% in the rural health centre. Table 10 below 
shows the PMTCT associated visits in each of the health facilities over 12 months in 
2005. The number of women attending the ANC in the urban facility was 3.4 times 











Table 10 : 2005 PMTCT Utilization Data per Health Facility 
Variable Urban Health Facility Rural Health Facility 
First Visit (ANC) 4654 1377 
Pre-test Counseled 4648 1194 
Tested 4417 1075 
Post-test Counseled 4407 1065 
mv neg. 3412 796 
mv pos. 995 269 
Women NVP (Deliveryf 631 199 
Follow up 259 23 
In the urban center the total number (Le. 5,544) of PMTCT associated visits includes 
the 4,654 first ANC attendees that were also offered VCT services, 631 HIV positive 
women that ingested NVP under supervision during delivery and the 259 exposed 
babies that adhered to follow up testing. In the rural facility, the total number (i.e. 
1,599) of PMTCT associated visits includes the 1,377 first ANC that were also 
offered vcr services during that single visit, 199 mv positive women that ingested 
NVP under supervision during delivery and the 23 exposed babies that adhered to 
follow up testing. The average monthly first visits to the ANC worked out to 
approximately 388 and 115 in the urban and rural facility respectively. This 
difference was mainly attributed to a much larger catchment population of 310,000 for 
the urban facility compared to 121,000 for the rural facility. In addition the lack of a 
reliable transport system and more sparsely populated settlements pose extra 
challenges for the rural community in accessing the health facility. 
Table 10 above and Figure 3 below reveals a decrease from the number of women 
counseled, tested, and then adhering to NVP treatment for those who tested HIV 
positive. 












Figure 3 : 2005 PMTCT Utilization Data per Health Facility 
2005 PMTCTUtililation Data per Health Facility 
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In the urban facility, 4654 women were attended to during their first visit to the ANC 
and 99.9% (4648) of them were pre-test counseled. Of those that underwent pre-test 
counseling 95% (4417) went on to be tested. Of the 4417 women that were tested, 
4407 (99.8%) agreed to receive their results in a post-test counseling session. The 
results also revealed that 995 of the 4417 women that were tested were found to be 
HIV positive, representing a prevalence of 22.5%. There is a further reduction of 
those that enter the PMTCT program as 15.5% (154) of the 995 women that tested 
positive refused to accept receiving NVP tablet. A total of 841 HIV positive women 
went on to enter the PMTCT program. However, 631 of the 841 HIV positive women 
that agreed to enter the PMTCT program went on to adhere to treatment8 during 
delivery. This represents a drop out rate of 25% at this stage. The largest drop out 
rate was during the follow up stage where approximately 59% (372) of the 631 HIV 
positive women that adhered to treatment, failed to adhere to follow up testing for the 
baby. These results were compared with the utilization and uptake rates in the rural 
facility and a statistical analysis was conducted to determine if there was any 
significant difference between the calculated proportions at the 5% level of 
significance (i.e. 95% confidence interval). The results are presented in table 11 
below. 
8 Adherence to treatment implies actual ingestion of the NVP tablet, as observed under the supervision 













Table 11: U Rates for PMTCT Health Facilities 
Uptake Indicator 
Women as % of new ANC 
Women as % of those Counseled 95.03% 
Women tested as of New ANC attendees 99.77% 
Received Results as % of those Tested 99.77% 
HN Prevalence 22.53% 
84.52% 
a'-"-'''I.IL''i~ NVP, adhering to treatment 75.04 








Z= -0.246, P=0.81 
Z= -3.816, P<O.OOOl 
Z=7.658, P<O.OOOl 
Although the facility had less than a third of the urban visits, the 
proportion new ANC attendees that were pre-test (86.71%), the 
proportion counseled went on to be (90.03%), the 
proportion attendees that were tested (78.07%), and the proportion of 
those tested that to receive (99.07%) were significantly less 
than the "~~'VU.UUJl5 proportions in the facility (P<0.001). differences 
in the two facilities 
acceptability VCT services by ANC and an extra one maturation""IIY"''''<>, 
of program in the urban relative to the facility. There 
was no significant difference in the prevalence of 22.5 % and among 
women tested in urban and rural facilities respectively (P>0.05), although in the 
rural facility, it is possible that those who were worried about 
have been more to be tested. 
in the proportion mothers that a .....'''''VLl.A.'' to enter the program 
the two (p>0.05), however was a significantly proportion of 
women in the that dropped out the urban facility (25%) when compared to 
the rural facility (13.1%). The majority of women are provided NVP tablet 
before giving birth and are then instructed to return to the facility delivery. 
However women who have been PMTCT ......"'('r.. .., one facility 
may deliver at or in another and are consequently recorded as 
outs should fail to return to the recruiting facility. The in drop 
out between rural and facilities may be attributed to the fact that in urban 
areas have access to a number of facilities for and are not as 1""'''£'''''''''-'' in the 











,""u"""""",, of facility as compared to clients in rural areas. Nonetheless, the exact causes 
of drop-outs among such women merit research. In rural 88% of 
those that to treatment during delivery, failed to comply with follow up 
Even this was significantly than the corresponding 
(p<O.OOOl) drop out recorded in the urban facility, the challenges faced in following 
up clients are similar in two facilities. of these include: 
• 	 The are woefully understaffed that at anyone time, there are 
no more two PMTCT competent nurses on duty. 
• 	 Follow up is conducted as an VY"".""""" activity PMTCT staff 
catchment population. The nurses usually no transport they 
have to walk limiting distance they are problem is 
even more acute in the rural area owmg to more sparsely populated 
settlements when compared to the setting. try and avoid they 
try to combine follow up activities with outreach activities such as 
immunization. However, trips are limited, infrequent, haphazard 
making it hard the PMTCT staff to synchronize their clinical schedules 
with outreach activities. 
• 	 Some deliberately wrong to avoid followed up, 
thus reducing number who can be followed. 
• 	 Other patients ""lH;Ul~;,"" residence and are untraceable 
• 	 Even being identified positively, some patients ever having 
tested for Often these are patients who not informed partners 
or members the family. 
• 	 The continues to rely on test kits require at 
months a HIV-exposed baby's serosatus can conclusively 
determined. a long time between birth and testing 
the chances of clients being lost to follow up. 
It is primarily for these reasons that credible evidence on the actual numbers of 












5.3 Costing of PMTCT services in the Health Facilities 
Table 12 below presents the direct costs and cost profile of providing PMTCT 
services in each of selected study sites over 12 months in 2005. All costs are 
presented in 2005 US$ and are further categorized by input type. 
5.3.1 Costs of PMTCT Services in the Rural Facility 
The total direct cost in the rural facility amounted to US$28,797.95 of which recurrent 
and capital costs account for 80.14% and 19.86% respectively. As illustrated in figure 
4 below the major cost drivers were personnel costs followed by medical supplies. 
Approximately 23% of the total costs were attributed to personnel costs while medical 
supplies accounted for 22 % of the total costs. Personnel and medical supplies costs 
accounted for 29% and 28% of the variable costs. Medical supplies costs were further 
sub-divided into costs associated with testing supplies, follow up supplies and 
delivery supplies. 
e lrec services ca egonze db nputTypeTabl 12: D' t costsofPMTCT t . Iy I 
Input Type 










Personnel costs 6,640.45 23.06% 19,619.63 31.84% 
Drug Costs 395.97 1.38% 4,004.87 6.50% 
Medical 
supplies 
Testing Supplies 5,591.44 19.42% 17,887.63 29.03% 
Delivery Supplies 791.01 2.75% 1,947.09 3.16% 
Follow up Supplies 54.02 0.19% 305.07 0.50% 
Transportation 2,275.11 7.90% 1,821.44 2.96% 
Maintenance 1,688.04 5.86% 1,517.86 2.46% 
Stationary 3,185.16 11.06% 3,278.59 5.32% 
Utilities 2,457.12 8.53% 3,849.30 6.25% 
Total Recurrent Costs 23,078.32 80.14% 54,231.50 88.01% 
Capital Costs 
Building Costs 998.76 3.47% 1,144.25 1.86% 
Vehicle costs 944.36 3.28% 976.92 1.59% 
EquiQment 795.69 2.76% 772.89 1.25% 
Furniture costs 990.27 3.44% 871.25 1.41% 
Training Costs 1,650.88 5.73% 2,694.80 4.37% 
Other Capital costs 339.66 1.18% 928.01 1.51% 
Total Capital Costs 5,719.62 19.86% 7,388.12 11.99% 
Grand Total 28,797.95 100.00% 61,619.61 100.00% 
Testing supply costs, which include the costs of mv testing kits, examination gloves, 











of the total costs. Medical supplies used during delivery and follow up account for 
the remaining 13% of medical costs and 3% of the total costs. Drug costs accounted 
for less than 2% of the total costs. The largest proportion of capital costs, i.e. 29% 
and 17%, were attributed to training and building costs respectively. 
Figure 4: Cost profile in the Rural Health Facility 














5.3.2 Costs of PMTCT Services in the Urban Facility 
In the urban facility, the PMTCT program cost a total of US$ 61,619.61 of which 
recurrent and capital costs account for approximately 88% and 12% of the total direct 
costs respectively. Similar to the cost profile in the rural facility, the major cost 
drivers were costs associated with personnel and medical supplies which accounted 
for approximately 32% and 34% of the total costs respectively. Personnel and 
medical supplies contributed 37% and 36% of the recurrent costs. 
Figure 5 : Cost profile in the Urban Facility 
TotaJ annuaJ cost profile (2005) by inputs in the urban heaJth facility 


























The majority of the medical supply costs were due to testing supplies that accounted 
for 89% of the total medical supplies and 29% of the total costs. Drug costs 
accounted for 6.5% of the total costs. 
In both facilities the high personnel costs are as a result of the staff time used to 
provide VCT services while the high testing costs relate to the high costs of the HIV 
screening (US$1.38 per test) and confinnation (US$ 3.69 per test) test kits as well as 
the high proportion of pre-test counseled women that went on to be tested (> 90% in 
both facilities). The low drug costs are mainly related to the low cost of the 
nevirapine tablet (US$ 0.24) and suspension (0.03 per ml) as well as the small number 
of eligible women that made it through all the steps and received NVP treatment. 
The differences in the costing results in the two facilities relate to the differences in 
utilization patterns of the two facilities. The costs associated with personnel, medical 
supplies, and drugs are all much higher in the urban facility because there were a 
greater number of women that underwent VCT, delivery and follow up in the urban 
facility. Hence the quantity of staff time spent on PMTCT, and the amount of medical 
supplies and drugs used in the urban facility was greater than that of the rural facility. 
5.4 Costs Categorized By PMTCT Component in the Health Facilities 
Table 13 below presents the costs of the PMTCT program after they were allocated to 
the PMTCT program components (i.e. pre-test counseling, testing, post-test 
counseling, delivery and follow up). 
Table 13: PMTCT element costs 
Urban % of Total Rural % of Total
PMTCT Element 
Facilit~ Costs facilit~ Costs 
Pre-test Counseling 12,239.26 19.86% 6,593.82 22.90% 
Testing 28,961.74 47.00% 11,853.17 41.16% 
Post-test counseling 10,520.96 17.07% 5,738.98 19.93% 
Delivery 5,282.24 8.57% 4,092.79 14.21 % 
Follow uQ 4,615.42 7.49% 519.18 1.80% 
Grand Total(US$) 61,619.62 100.00% 28,797.94 100.00% 
VCT costs (i.e. pre-test counseling, testing, and post-test counseling) constitute 
approximately 84% of the total costs in both facilities. In both facilities the costs 
associated with testing were the major cost driver accounting for 47% and 41% of the 
PMTCT costs in the urban and rural facility respectively. The costs associated with 











rural facili ty respectively. When the element costs were broken down 
to the input varying cost emerged. 
Table 14: PMTCT element costs b 
Pre-test 





Personnel cost 1825.54 31.81 949.96 44.27 8.53 




Trans ortation 687.02 10.68 343.51 8.39 2.55 
Maintenance 509.74 7 254.87 6.23 9.82 1.89 
Station a 961.83 865.97 7.31 14.95 480.92 11.75 18.53 3.57 
Utilities 741.98 11.25 668.03 5.64 11.53 370.99 9.06 14.29 2.75 
Sub-Total 5,106.93 77.45 9,817.28 82.82 74 76.89 3,250.85 79.43 490.54 94.48 





In the rural facility as shown above table 14, "V~JlHv~ costs were the major input 
and post-test and delivery components forcosts in the 
and 23% of costs respectively. The largest cost in the """".u~ 
component was the testing accounting for 47% of the costs. Drug 
costs (i.e. cotrimoxazole), which were major cost in the follow element, 
constituted 65% of foHow up costs. In all the elements recurrent costs 
constituted more than of the costs. the capital costs, training 
building costs form the major costs in aU PMTCT conrtponen.rs 
In the urban facility as shown in table below, personnel costs were the major cost 
.........F>
driver pre-test and ,",V'Hi.;)',",..l."" components for 58% 
54% of the costs. Medical "......'IJ..,~'" delivery) formed the largest input 
costs in the and delivery v1"1""I"" Medical supplies accounted of the 












cotrimoxazole) constitute the largest component, approximately 82% of the follow up 
element costs in the urban facility. 

























Personnel cost 7,157.39 58.48 5,570.40 19.23 5,702.59 54.20 949.96 17.98 239.30 5.18 






216.99 4.11 3,787.88 82.07 
Medical 
Supplies 
N/A N/A 17,887.63 1,947.09 36.86 305.07 6.61 
Transportation 541.86 4.43 514.93 1.78 513.77 10.68 220.68 4.18 30.19 0.65 
Maintenance 451.55 3.69 429.11 1.48 428.14 4.07 183.90 3.48 25.16 0.55 
Stationary 975 .35 7.97 926.88 3.20 924.78 8.79 397.23 7.52 54.35 1.18 
Utilities 1,145.13 9.36 1,088.22 3.76 1,085.76 10.32 466.38 8.83 63.81 1.38 
Sub-Total 10,271.29 83.92 26,417.17 91.21 8,655.03 82.26 4,382.25 82.96 4,505.76 97.62 
Capital Costs 
Building cost 340.40 2.78 323.49 1.12 322.75 3.07 138.64 2.62 18.97 0.41 
Vehicle costs 290.63 2.37 276.18 0.95 275.56 2.62 118.36 2.24 16.19 0.35 
Equipment N/A N/A 674.40 2.33 N/A N/A 98.49 1.86 N/A N/A 
Furniture 259.19 2.12 246.31 0.85 245.75 2.34 105.56 2.00 14.44 0.31 
Training 801.68 6.55 761.84 2.63 760.11 7.22 326.50 6.18 44.67 0.97 
Other capital 276.07 2.26 262.35 0.91 261.76 2.49 112.44 2.13 15.38 0.33 
Sub-total 1,967.97 16.08 2,544.57 8.79 1,865.93 17.74 899.99 17.04 109.66 2.38 
Grand 
Total 
12,239.26 100 28,961.74 100 10,520.96 100 5,282.24 100 4,615.42 100 
5.5 Unit costs of PMTCT service components 
The unit costs associated with the different PMTCT service elements are presented 
below in table 16. 
Table 16: PMTCT service Unit costs 


































Unit costs 5.52 11.03 5.39 20.57 22.57 
The calculated unit costs were; US$2.63 per mother pre-test counseled, US$ 6.56 per 











baby set adhering to NVP treatment during delivery, per mother 
baby set adhering to follow up the urban In the rural facility 
calculated unit costs were; per mother pre-test counseled, US$11.03 
mother tested, US$5.39 per mother post-test counseled, US$ 20.57 per mother and 
baby set adhering to NVP treatment during delivery, and 22.57 per mother and 
set adhering to follow The calculated cost mother attended to 
pre-test .....'.:>Lll,l;O':: and post-test was US$l,",V ..H • .:>\,lUJ",-, 
in the urban and facility respectively. 17 below shows 
costs each of the down into input (personnel, supplies, 
etc) to an idea of what exactly drove the differences unit costs between the two 
The major cost under each activity are bold type. 
health fadlit 
Delivery Follow Up 
unit cost unit cost 
(US$) (US$) 















Maintenance 0.10 0.43 
Stationa 0.21 0.21 0.81 
Utilities 0.25 0.62 
Sub-Total 2.21 5.98 9.13 
Capital Costs 
4.77 0.92 1.92 







calculated unit costs the rural facility are higher than those in urban facility 
as PMTCT rural area proportionately covers women. The 
higher unit costs rural area also some indication 











constant unit cost in calculating the costs of scaling up, the higher rural unit costs 
have been used in this study. The total direct cost of scaling up the program in 2006, 
2007 and 2008 are presented in table 19 below. The total direct costs of the PMTCT 
program in each year are also discounted and presented in US$ 2005 net present value 
(NPV) 
Table 19 : Costs of Scaling u~ to the ~ro~osed national targets 
Unit % of % of % of2006 total 2007 total 2008 total 
costs total total totalcosts (US$) costs(US$) costs(US$)(US$) costs costs costs 
VCT 21.94 4,681,438.78 80% 7,022,158.17 79% 8,192,517.87 73% 
Delivery 20.57 729,663.67 12% 1,042,376.67 12% 1,563,565.01 14% 
Follow u~ 22.57 440,462.38 8% 800,840.69 9% 1,458,674.11 13% 
Grand total 5,851,564.83 8,865,375.53 11,214,756.99 
NPV(2005) 5,681,130.90 8,356,466.71 10,263,091.32 

The average direct national program costs in 2005 US$ for the PMTCT intervention 
are US$ 5.68 million in 2006, US$ 8.36 million in 2007, and US$ 10.26 million in 
2008. The total costs of scaling up over the three year period (2006-2008) are US$ 
24.3 million. The average direct costs of the program increase as the program is 
scaled up to the 2008 scenario. The major cost driver of the PMTCT program is the 
VCT component that constitutes over 70% of the program costs in each year (figure 
6). 
Figure 6: Cost profile of National costs of Scaling up PMTCT 
Cost profile of PMTCT National costs 
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2006 Total costs 2007 Total costs 2008 Total costs 
As the numbers of HIV positive women and baby sets that enter the program and 
adhere to follow up reach the proposed 2008 targets, the proportion of the total costs 











to 14% and respectively. While the proportion of national costs accounted 
for by VCT component decreases 80% in 2006 to 73% in 
the proposed national theofIn order to assess the 
PMTCT costs were compared with projected 2006-2008 health 
budgets and the allocations for the national reproductive health program. 
Table 20 below outlines findings comparison. The scaling up of PMCT 
was budgeted as part of an integrated reproductive program that 
also includes the costs of program management, 
illness (IMCI), vaccinations and drugs, safe motherhood program and community 
mobilization. results that there 
L~F¥'"L~'~ ...".,,"F.'v...~... of childhood 
be budgetary constraints if scale 
up program met the proposed national targets. 




Estimated Total Healtb % of Total Budget for 

PMTCT Budget(US$) Healtb Reproductive 

Costs(US$) Budget HeaJtb(US$) 

2006 estimates ,"'I'.Ju,uuk.15 
2007 estimates 8,356,466.71 174,445,687.18 4.79% 6,705,216.44 -1,651,250.27 
2008 estimates 5.01% 
a proportion of the proj cted total health budget, estimated national PMTCT 
n ..",rr""'rn cost would require approximately % in 2006, 4.79% in 2007 and 5.01 % 
in to meet proposed up targets. However, results also show that 
even if entire allocation for reproductive health program was used for 
PMTCT be still a deficit US$1.44 million in 2006, 
US$1.65 million 2007 and US$1.97 million 2008 in required PMTCT costs 
to meet the proposed targets. total deficit would amount to approximately 
US$5.06 million over three year period (2006-2008). The deficits 
PMTCT program are likely to much as a proportion of the reproductive 
health budget is used for other programs like immunization, IMCI, and the safe 
motherhood program. The discrepancy points to need to the proposed 
patient targets or revise allocated reproductive health budget if it 












identify and allocate additional resources to the PMTCT program. It is also evident 
that at least an additional US$5.06 million would need to be allocated to the 
reproductive health budget to meet the 2006-2008 proposed PMTCT package. 
S.7 Sensitivity Analysis 
In order to test the robustness of the costing results of the scaled up PMTCT program, 
a one-way and multi-way sensitivity analysis was conducted. The variables used in 
the sensitivity analysis were based on identified cost drivers, uncertainty around key 
input variables and assumptions used in the costing model. In the simple one-way 
sensitivity analysis the selected variables are varied one by one between a low case 
and high case scenario to determine the impact on the projected average national 
PMTCT costs of the 2008 scaled up scenario. In the multi-way sensitivity analysis, 
the effect of combining all the selected variables in the low case and high case 
scenario on the projected average 2008 national PMTCT costs was examined. 
Although it may seem unrealistic to combine the variables in this way, it provides an 
indication of the plausible range of program costs that would be incurred by the 
government in the scaled up scenario. The base-case value of each selected variable, 
the range of values examined and the impact on the projected average 2008 PMTCT 
national costs in the one-way sensitivity analysis are displayed in table 21 below. The 
low and high case scenario values used in the staff time variables were obtained 
directly from actual observation of activities in the pilot facilities. The proportion of 
time spent on PMTCT was established by timing a total of 50 clinical consultations. 
The low and high case values used in the uptake rates and other key variables are 
based on actual country level parameters obtained from the Central Board of Health 
(CBoH) and the Central Statistical Office (CSO). The last major column is the most 
informative as it shows the percentage change from the 2008 PMTCT costs in the low 













% Change from 
2008 Total projected 
Scenario 
Baseline from Baseline from Costs For PMTCT 
case Low case Baseline for (USSI0 63,091.32) 
High case Low 
Case 
A) Staff time 
24 -17% 20 67% 40 -1.03% 
26 
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show that the costing model is moderately The results of the 
robust with "'","Up:;'''''' variables causing small percentage 
projected 2008 costs of US$1O,263,091.32. The costs were 
fairly to..""h,nC" costs of HIV testing kits, building 
training costs. was to using either the more 
h"",..,,,· .. generic versions. For instanceoriginator cost 
207% would only ~....,.~... costs by 
0.39% and .u,-,.",,,,,,,"..,,}:;, nevirapine syrup by 202% result in a 
0.03% the program costs. However the model moderately 
sensitive to cotrimoxazole, which relates quantity that is 













Among the other key variables the model was most sensitive to variations in the 
antenatal HIY prevalence, exchange rate, choice of discount rate and the national 
antenatal population. The impact of the variation in the antenatal HIY prevalence is 
associated with the numbers of HIY positive women that proceed to further 
confirmatory testing, NYP therapy and follow up testing for their babies. Scaling up 
the program in a scenario where the HIY prevalence increases by 13% results in a 
19% increase in total costs while a reduction of 13% in HIY prevalence leads to a 
corresponding 18% reduction in the total costs. This finding augments the need to 
intensify primary prevention programs of HIY as outlined in the internationally 
accepted four pronged approach to PMTCT. 
Holding all other things constant, a 19% appreciation in the Zambian Kwacha against 
the US Dollar would lead to a 24% increase in the amount of US dollars needed to 
locally fund the PMTCT program, while 39% depreciation would lead to a 28% 
reduction in the US dollar amounts required. Given that the health budget receives a 
substantial amount of donor funding in US dollars, volatility in the exchange rate 
would make long term planning and budgeting for PMTCT scale up more difficult 
and less predictable. 
The use of a higher discount rate (i.e. 10%) places a lower value on future costs than 
using 3% and therefore, when the costs are discounted to net present value (NPY), a 
higher discount rate leads to a lower net present value. Using a lower discount rate 
(e.g. 0%) leads to a higher net present value. A 3% discount rate has been used in this 
study to ensure that the results are comparable with studies conducted in other 
developing countries. 
The model was moderately sensitive to variations in use of staff time used for pre-test 
counseling and post-test counseling given for a HIY negative result and less sensitive 
for a HIY positive result. Using this staff time less efficiently (i.e. high case) leads to 
increase in the total costs of the program. This underscores the necessity to include 
time management techniques in the YCT training curriculum to ensure that staff 












managerial challenge for ""',1<,£""'" of the ..n('r""''''''' in the an 
Due to paucity of data on adjusted unit costs for levels program 
conducted to determine coverage, a analysis 
analysiscosts for the 2008 up scenario. results of multi-way 
are shown 
Total Costs % Change 
Scenario Baseline Under from Baseline 
Scenario 
Combination of All Low case 
Scenarios (3 % discount 10,263,091.32 8,326,099.77 -18.87% 
Combination of All High case 
% discount 
10,263,091.32 12,370,068.34 20.53% 
The average national costs are estimated to be million all 
inputs are combined in the low case scenario and US$12.37 when all 
are .....'-'.'uuu.....' ... in the case 
5.8 Human Resource Requirements 
Many studies have identified PMTCT as a cost-effective intervention, but have 
estimated the human resources to provide the services to reach scale 
Human resources, in numbers have now identified 
as one of prerequisites a well functioning health system that is capable of 
responding to the challenges imposed on it by a growing crisis. an 
'Ul"U"VU of human resource up of Zambian PMTCT 
program was calculated this study. number of full time equivalent (Ff£) 
required to the services is based on the time required to 
complete each """"I'UU element and the projected utilization of 2008 
scaled up scenario. in the U~"_""~"U facilities, it was noted that 
midwives were the ones with providing PMTCT services (Le. VCT, delivery 
follow up). Therefore personnel in to midwives. Table 
presents the estimated number required each element and total 















Total )1~rE required for 
services 
on the targeted scenario, a total 476 FfE would be required to 
provide PMTCT services. The distribution of follows the cascade pattern of 
utilization of services in the facilities. Out of 474 FfE midwives, (56%) 
required counseling 113 (24%) for testing 73 (15%) delivery 
and (5%) for follow up The bulk counseling (Le. 52%) 
would be on providing counseling services. 81%(92) of the 1 
midwives required for services are as a result of the projected HIV 
put this requirement into some perspective it is compared with the 
midwives would be available in the Zambian public health 
the scale up Table the projected numbers of midwives in 
2006, 2007 and 2008. These projections, ceteris paribus, are based on 2005 actual 
number of midwives annual of graduates local training 










Table 24: Pro'ected Staff Stocks 2006-2008 
Attrition 2005 2006 2007 2008
Staff 
rates Actual projected projected Projected 
Midwives 2,273 2,389 2,443 
It is projected that available midwives in 2006; 2,389 

2007 and 
 face value it would au ..''''a. midwives that 
would be available in 2008 could easily accommodate 476 FIE midwives 
required for PMTCT. However, keep in mind that current levels of staff are 
already struggling to provide basic health services, immunization, to a growing 
population with 2005 staff (midwife) to ratio of 1:4,795. 
Therefore one number of staff the provision 
of basic health at current staff to population ratios to the number 
of midwives required to PMTCT services in the 2008 ""''''." ... up scenario. By 
comparing these numbers with the projected levels that will be 
available in 2008, we into focus the feasibility of PMTCT at current 
staff to population ratios. By combining an estimated 2.1% population growth 
with an estimated 2005 national population of 10.9 million to population 
ratio of 1:4,795 of staff required to in 2008 is 
calculated. As ""{1,Uln below, 2,421 to provide 

health additional 476 required to 

scale up PMTCT 
 a projected total of 2,897 
Table 25: 
Total Total HR Gap as GapNeeded for projected Available % of Staff 
Staff PMTCT Staff (2008 needed for 
(2008) needed projected) PMTCT 
[1] Ratio [2] [31= [1] + [2] [4 [5]/[1] 
476 2,897 95%Midwife 
When the total projected u,...... v''''. midwives required is compared to 
that are projected to be 2008, there is a shortfall of 












projected rl1nnh,"t' in 2008 population able to 
meet of PMTCTstaff Clearly the shortages skilled 
staff the PMTCT process unless are taken to address 
what is already a serious human resource crisis. It is also predictable, that unless 
greater are made in annual number skilled graduates, 
retention and addressing root causes of attrition, Zambia will not achieve 
the set out 'VpnH"rp targets within frame. 
Based on findings from the facilities, one of the major capital costs would 
be costs. According to the PMTCT scale up plan, midwives would 
a 4 week training package that would comprise of 2 weeks of theoretical 
training by a 2 week practicum a pilot site. The inputs in the training 
materials booklets, chalk, and pens), 
transportation, accommodation costs and meal allowances participant and 
shows that the estllmated training costs for estimated 476 FIE 
would amount to US$413,000. equates to an 
cost of US$90,121.85 over a useful life of 5 Possible savings on 














x [4] [4] 
Table 
Midwife 476 867.08 412,907.94 4989.23 2,375,889.35 
total annual salary costs would amount to US$ 
in the salaries would to maintain 
npr.<>Tlyrp given that the gmreno.m,ent intends to spend 90 million annually (2006 
to 2008) on salaries for health workers, the cost required to employ the extra 
an increase of 2.6% in healthwould 












CHAYfER 6: DISCUSSION 
6.1 Introduction 
cost analysis conducted in 
this study. The on the cost estimates, utilization 
patterns in the health the estimated total costs human resource 
requirements and their for the scale up in Zambia. The chapter 
ends by examining limitations of the study. 
6.2 Costing in the Health facilities 
study results the PMTCT program cost twice as much in the 
urban facility the rural health facility. this can not be 
chapter the 
u",.,nr""",rt to mean health facility was more eIIlCli~nt than the 
health facility. The cost could be by 
mix, and utilization in the two facilities. the urban 
covers a much larger catchment population and is therefore allocated a 
proportion of available government resources as compared to the rural facility. 
addition, the patterns in the meant that in comparison 
to the program in facility, a higher amount time, medical supplies, 
UUJlCAV<"'C>and other were used. An <U...."J'u>..)'.. of the total cost 
showed an 80/20% and division hpl'UI~'P recurrent and capital costs 
rural and urban health respectively. a similar 
capital and recurrent costs from similar studies et a1. 2001; Desmond 
and Boyce 2004). In most costly was """",uv. costs, followed 
medical supplies and costs associated with stationary, utilities, 
and transport. to several studies conducted on primary health care 
personnel costs were found to be largest In both facilities 
et costs proportion 
dedicated to which underlines of stressing for 
efficient management of this resource for success. Transport costs were 
higher in the rural giving some the higher costs 
outreach services a sparsely populated rural area. Drug costs accounted 












earlier on up PMTCT as one conducted by Wilkinson, Floyd 
et a1. (1999) had focused on drugs as the cost driver, it is now that 
following the availability cheaper ARV the main cost drivers would be the 
costs associated with enhancing the health to deliver such (Galbraith 
and Bennish ; Marseille, Onyango et a1. 2003; Desmond and Boyce 2004). 
Making additional investments in medical supplies and administration 
would go a to alleviating a bottlenecks in up program. 
Even though investments to budgeted there 
would likely positive spin-offs terms of improvements reproductive 
health services such as antenatal services. Capital costs a smaller but 
significant portion of the total cost with training and building costs being the main 
cost drivers. costs have been appropriately annuatized over a number of 
but are to account for financial start up for the PMTCT 
services to provided in quantity and The current 
dilapidated state of most of the infrastructure understaffing that is 
currently prevalent in the health make such investment crucial for program 
success. such capital costs form a significantly large part of the total costs, 
should explore more strategies to share costs by reinforcing program 
PMTCT with other reproductive health programs. 
When costs were broken down into PMTCT pre-test counseling, 
testing, counseling, and follow up), the from both the 
and rural health facilities showed that the largest costs are associated with voluntary 
\,AI'''He'''''',Hl''. and testing. In both VCT costs ( counseling, testing, 
and counseling) for 84% of the costs. Within 
costs associated were the major cost accounting for 
and 41% of the total direct costs rural and urban respectively. 
'-'''''''VA'''''''"''''' in the costs in two facilities related to the differences 
of women that used and advanced to the confirmatory testing 

the health facilities. The urban facility recorded times the number that was 

tested the rural facility. analysis shows that the costs of will 













When the ,V",AUF. conrlOO was broken input costs it emerged that 
largest input was the testing supplies which test kits. 
constituted 47% 62% of the testing "r.".......,'",o costs in the 
facilities respectively. These results are similar to findings of et al 
(2003) and et al (2005) that found that was the main cost driver the 
PMTCT due to the high cost Abbot test used for screening and 
Capillus test confirmation. The algorithm in this study shows that 
each woman accepts to be to an Abbott test 
(US$1.38 and if the test is test (US$ 
3.69 per test) is conducted. The high costs assocllate;d with ---r-.--, due to .vv....n 
the that services serve as a to accessing 
Onyango et al. 2003). any of the women to access services 
they must first determine their HIV status. This underscores the to recognize 
VCT as an important that to be scaled up if the PMTCT 
nr{~ ....... ~rn is to In provides an to strengthen 
measures by allowing positive PMTCT 
program and by reinforcing about HIV found to be 
I.UU,>UI.,,, ...,u (Ministry of Health(MoH) As drug (nevi rapine) costs are no longer 
cost driver, the next in reducing PMTCT costs mainly in 
UU\..,UI1Z, costs associated with This would include costs associated 
.v"....f'> kits, testing and procurement. alternative 
as the use of prick testing and saliva testing as opposed to 
the use of syringes and test also need less (Marseille, Onyango 
et 2003; Stringer, In view shortages, this 
would allow program flexibility to less skilled and 
cheaper workers such as traditional birth attendants and cmnrrlU health workers to 
the testing and Shifting of tasks such as and counseling 
would also free up midwives to conduct other activities as deliveries and follow 
up. With this extra capacity, economies of scope would lead to lower costs 
PMTCT Further cost could be accomplished by 
procuring the testing bulk as opposed to the erratic and inefficient 
procurement arrangements that characterize the current .~".. " ••~" management 











6.3Utilization of the Health Centers 
In tenns of the patterns in both facilities, it is that a cascade decline 
pattern is HV •• ''''',\.1 number of women who attended first antenatal visit at 
the facilities, eventually enter the PMTCT As already noted 
testing is point for PMTCT services and must be widely 
available for to succeed. Testing and pregnant women who yu.,.......'uF, 

are mY-negative about mv infection helps .. uninfected. For pregnant • ...,,,....u 
women who are and know their help 1) 
make infonned """"""'''JU''' about their pregnancy, 2) appropriate and timely 
interventions to MTCT, 3) secure early access to treatment, care and 
support 4) disclose their results to and family members and 4) 
receive up and ongoing health care for themselves and their mv-exposed 
infants et aL 2000; World Health Organisation (WHO) 2004b). In 
both more than 90% of those that were accepted to be tested. 
high aCC{~ptaIDll1t attributed to use one-on-one counseling and 
the opt-out strategy in each of use of the opt-out ....",.......,..F, 

strategy has VCT uptake as written consent is no longer 
testing (Ministry of Health 2006). The entails that all women 
attending <un'vu« clinics go through mv ~.."'"'.. , ....... during which they may opt not 
to take test. This counseling is conducted in a private office that allows 
woman to a decision without any The high acceptability 
tested provides a window opportunity to strengthen 
programs at increasing treatment, support prevention, including 
The is that women may not of the counseling 
test Male involvement is still a "''''~U'''F,'''' which may ne~:ale to 
"'..1';"....,.. the program and sensitize to benefits of knowing status. 
are current plans to invite men to come to the facilities over 
.....,',,<J,..~ and testing. However of staffing and enthusiasm the male 
has posed to be the greatest implementing such a idea. It is 
.""1::;,"'.... that with greater even a greater proportion of women 










The proportion of ANC <1lU:;UUlJv;:) that were tested was 
significantly larger in the than facility 
99.9% and 99.8% of the new antenatal care tested, 
while in the rural health facility 86.7% and the new antenatal care attendees 
were counseled and tested respectively. This some the challenges 
involved in scaling up PMTCT services in rural areas. challenges are associated 
with lower acceptability of the counseling antenatal attendees, 
to deliver antenatal care and higher levels to urban 
facilities. A major difference that impacted on urban 
facility has registered midwives who have 
administering a PMTCT program than their enrolled ""V.H'-'"~'''.,,''' rural facility. 
Furthermore, the urban facility had an extra one year maturation during which 
the extra experience in administering such a p[(H.l.ram 
than in the rural facility. 
In both facilities more that 99% of those that were to the 
This collection of results is .......,....."..... is 
new in both of the study use of 
rapid HIV test kits that are able to provide conclusive 
finding is consistent with findings of similar of III 
a of countries (Scotland, Terjlingen et al. 2003; et al. 
also highlighted that 22.5% and 25.02% of those and 
1.<:......1111.1.... " respectively were found to be HIV -seropositive. This is 
higher than the national antenatal seroprevalance of 19%. It might be argued that 
be related to self-selection bias. It is plausible that those who 
exposed to the virus or are more worried about their HIV status are more 
to VCT services and then go on to get tested (Kombe and Smith 2003). a 
the seroprevalance among those who seek to be tested would be 
reported prevalence in surveillance studies that employ random 













and instead it is more likely that these clinics serve catchment areas with higher than 
average seroprevalence. 
The drop out rates among my positive women at the stage of joining the PMTCT 
program, delivery and follow up threaten the success of the scale up program. The 
results showed that 15% of the women that tested positive in both facilities refused to 
actually join the PMTCT program. Of those that entered the program, 25% in the 
urban facility and 13% in the rural facility failed to ingest nevirapine under 
supervision in the facilities. This is closely related to the fact that only 61 % of total 
deliveries are supervised by a trained health professional in Zambia (Ministry of 
Health 2005a). The remaining 39% are conducted at home, mostly with the aid of a 
traditional birth attendant (Ministry of Health 2005a). Seropositive mothers who 
accept to enter the program are given NVP in the ANC with instructions on when to 
ingest it. Because no follow-up was undertaken by hospital and project staff, it cannot 
be conclusively established whether the women who gave birth at home ingested 
nevirapine or not. The effectiveness of the programme could be potentially improved 
by using traditional birth attendants to follow-up mothers in communities, improve 
adherence to treatment during home deliveries and to refer antenatal and postnatal 
mothers to antenatal clinics. 
As a proportion of those who ingested nevi rapine during delivery in the facilities, 
59% in the urban facility and 88% in the rural facility failed to adhere to follow up 
testing. The drop out rates indicate that mother-child follow-up has been one of the 
most challenging activities of the Zambian PMTCT programme. Currently, the 
National PMTCT program indicates that an ELISA test for children at 18 months 
should be conducted (Ministry of Health 2006). Early testing of the babies is 
hampered by lack of necessary laboratory tests such as PCR while my testing of the 
babies at 18 months is minimal because the children are not brought back for testing. 
The result is that while the programme might be effective in preventing MTCT, very 
little data is currently available on the number of infections averted. When staff 
undertake active tracing, they are unable to find the children or do it infrequently due 
to staff shortage. This lack of PCR testing for babies also impacts negatively on the 












follow Cotrimoxazole can only be once the 
exposed as negative. use of ELISA at means 
that each "''''',,''JC''''.J baby is prescribed UU'JA"'LVlv for a months 
regardless actual serostatus. The cost an 18 month cotrimoxazole prophylaxis 
regimen was at US$ 14.63 per baby. PCR could be potentially cost saving if 
it would cost than 14.63 per baby. use of PCR may help to bring the cost 
associated cotrimoxazole prophylaxis down as it is able to determine the 
serostatus hours of those that test would need to 
take '''''''''"It'll'JA<J<LV.• ,, prophylaxis. 
It is from the facilities that HIV stigma is still a problem 
PMTCT program. It was noted that some the major failures 
follow up are aCMV,","U..,,'U with stigma. These include the fact that: 
.. patients deliberately address to followed up 
.. patients change « ... ,un..·"",.,., are untraceable 
.. being identified, some fJa ...vu." deny ever mv . 
these are clients who not disclosed status to their friends 
by HIV women to join the PMTCT effect of stigma 
causes of drop outs merit Other 
in follow up component poor access to for the women as a 
result the long distances to cover and the reliable and 
It is primarily to such reasons that actual numbers of 
mtect]OIIS and hence the impact of the program the Zambian context is currently 
6.4 costs 
of the unit cost calculation are Table 16. most costly 
state-sector PMTCT provider is the urban facility. However, on rural 
counseling, '_~"".,",'facility has higher costs PMTCT component 
counseling, delivery, follow up) than the facility. The unit cost 
the urban facility were 1.58 per mother attended to for VCT (pre-test 










to treatment during and US$ 17.82 per baby set adhering to 
follow up urban facility. While area the unit costs were 
UIVUl"'.US$21.94 per attended to for VCT, US$ 20.57 per mother and baby set 
adhering to treatment delivery and US$ per mother and baby ser 
adhering to follow up testing. The unit costs in rural facility are higher the 
unit costs as the total costs the area proportionally cover 
fewer women than in the urban area. costs in the rural facility provide 
some indication diseconomies of is scaled to 
area. Scaling may be I'Ac,Lp"t"tpl'tn but is likely to be less .... LLJ'''''..... than 
running pilot With expanded and scale, the unit costs are to 
increase and the 'vAA'J"''' may not be as due to the additional of 
home and tracing exposed babies. 
The calculated costs in this are ,""v."",,,, with some of the findings of 
earlier ",v"."""u studies on PMTCT Saharan Walker 
(2003) that the cost of VCT ..<::on .... "" US$ 4.15 to mother 
attended. There was a greater than fourfold variation in costs of HIV per 
woman ranging from US$4 to US$18.50 based on evidence Zambia 
and ........~..~.~ respectively (Scotland, et al. 2003). The wide variations are 
a reflection of differences ""V"UAJ,,,- methodology used and structures 
areas where labour is more expensive, 
cost providing counseling Therefore one of major strengths 
of this is that it is based on actual pilot cost VCT unit 
costs study significantly US$ 4.31 VCT cost calculated Kombe 
and Smith (2003) in Zambia. Kombe and Smith (2003) conducted an incremental 
the PMTCT and hence underestimated the economic cost of 
resources like and staff which been found to be 
"'Jl',uu.,vUJ'" cost drivers in this study. 
Unfortunately these unit costs us with no the "quality of 
in the facilities. quality of care was not evaluated this study and 












UvlLJvllUC> on the extent to which they can 	 It is therefore to 
note some of the characteristics of the sites. 
1) Sites used integrated approach: the PMTCT program is integrated into the 
reproductive and childhood programs such as the antenatal care and safe 
motherhood delivery This entails that mothers a holistic 
package once they start to attend 
2) Strong manall~em:em support: in each of the it was found supportive 
supervision from both the provincial health and the district management 
teams to leadership scaling up the The 
mentioned offices provided opportunities to find quick solutions to 
operational problems that could not be handled by the clinical staff. It is 
through mechanisms that strong were forged clinical 
staff and district health teams. 
3) 	 Steady supply of COJlsuma.ble;s: an examination the J.uvv,,,,,,-,, and pharmacy 
records showed that there was a good of crucial such as 
kits and drugs. 
4) 	 Strong political support: both sites, it was also reported that the community 
and as the had supported 
establishment of PMTCT in each of the districts by actively sensitizing and 
mobilizing community members about program. 
to Zambia, for results to 
relevant to up program 
6.5 National costs of scaling up PMTCT 
The 2006-2008 projected national costs of PMTCT ..All,,.,, • .,... are based on the 
projected national utilization the projected antenatal population, antenatal mv 
prevalence, calculated rural unit costs. these costs should have 
on unit costs that were for different levels of however this is 
absent. rural unit costs were used to minimize a possible underestimation bias in 
the total costs. In reality it is likely that as program a higher the 
average costs would than area. The extent to 
which unit costs will rise largely depends on diseconomies 










cost that includes both and variable components, this study assumes that in the 
long run fixed costs will be variable additional infrastructure will available) 
that this will not be via excess capacity in the facilities. 
The costs of scaling to the national are It was 
estimated that the total costs of up the program over a three year (2006 
to 2008) would be million. estimated costs 2008 up 
scenario alone were US$ 10.3 million. The study was conducted from the provider's 
perspective therefore the an estimate of the requirements scaling 
PMTCT public sector. On the side, these cost are 
related to providing reliable and confidential voluntary testing counseling; 
antiretroviral and their administration; equipment deliveries; 
counseling support for infant monitoring, and follow up for the first months. 
cost borne by relatives friends, such as transport costs, lost 
form and other pocket were excluded. Therefore by only 
considering the costs borne by Ministry of the actual costs have been 
underestimated as societal costs were not included. Nonetheless, it provides a guide 
to policy makers on the needed to meet the proposed 
Similar to the cost profile of La""'u.......,,, , VCT forms main cost 
in the national PMTCT program v"" ....... 'Ul overall program costs in 
each This again the fact next frontier reducing 
costs lies in VCT costs which are mainly a result the high costs of testing. 
delivery and follow up the remaining but 
"''''UHll'-<.ll.lL proportion costs. direct costs with and 
follow up are as a result fewer numbers mv positive women that actually 
enter the adhere to NVP treatment and follow up testing. 
In to assess the feasibility of up, it is to link the projected 
estimates to the Medium-Term Expenditure In addition, 
sources of the prepared budget should as available 
including any gaps, in order to facilitate mobilization of resources. 












_,..,...._... to HIV infected women Zambia would account no more than 
health budgets, would be constraints ..:>uu' • .uu 
program meet its proposed targets. Based on allocations for the 
reproductive health budget of which PMTCT is a there would be a total projected 
of at least million over the three period (2006-2008). 
.uUII-'~"h' that either the DrOIDo~sea national targets up program will to 
or a greater amount resources to be allocated it Oe(:orrle 
that the are being met. obvious question where 
would such additional resources come from? 
6.5.1 Availability ofAdditional Funding 
Over the years availability of global pooled funds for the health sector has 
continued to Currently a number targeted funds have made 
available to the Government Fund for 
Malaria; Presidential Fund HIV/AIDS; Global Alliance on 
Vaccines and ................,.....,"'uv (GA VI); and National Response to HIV / AIDS u LJ.....,..V)," 
(ZANARA) (Ministry Health 2005b). of US$5 million was eXl)eCreO in 
2005 for various programmes these funds (Ministry of Health 
2005b). As these come in the form of vertical programs, they not been 
QVI.,VUllL\."U for in of Health's term expenditure budget 
for 2006-2008. Ministry should of these 
them into the basket funding 1.11L/L/''''<111''',I11':> to complement its up 
efforts to address the targeted health PMTCT. GF ATM funding is 
intended to be additional to existing funds target diseases, channeled 
through the health sector basket funding or through direct of health 
facilities. is a somewhat unrealistic expectation, given the fungibility of 
different .un':''''-''I,!'; sources available to and is to 
the recent emphasis to strengthening recipient government In 
prioritization and resource allocation. Such should be tracked if possible, 
through analysis shares of total discretionary spending 
allocated to the health sector (and to where treated (Lake 
2004). This achieved by some form of public expenditure 












In addition to these funds, government should the proportion of the 
discretionary government spending on health to the agreed Abuja target of This 
is currently set at between and 11% (World Health Organisation (WHO) 2002). 
the importance of health economic development, prioritization 
should given to funding the health sector (World 1997). lack of 
adequate for the sector to derail efforts for PMTCT. 
Increased allocations coupled with the substantial debt from the Indebted 
Poor Countries (HIPC) initiative would provide policy makers with more resources 
for critical sectors such as health (Ministry 2005b). 
6.6 Sensitivity Analysis 
one-way multi-way was to test the 
vY,n,,'"'''' of the estimates to assumptions that were used in study. 
The simple one-way analysis analyzed the in key variables associated with 
and medical costs, HIV prevalence, antenatal population, and 
VVA""""H In the cost data used in a costing is not 
uncommon (Briggs 2001). The costs of Nevirapine and medical supplies such 
as HIV test were valued at market costs from the current suppliers to 
Ministry of Health. However, the results were not sensitive to possible 
imprecision and variation the estimated costs of HIV test kits. 
Using reasonable assumptions on use of in providing PMTCT 
that the model was moderately sensitive to inefficient use staff time. 
Given personnel costs form a proportion of the costs, 
management must ensure this resource is used efficiently. The are comparable 
to found Galbraith Bennish (2001). They argued the greatest 
managerial challenge from a program perspective would the efficient use of staff 
time. study findings corroborate this showing that using staff less 
efficiently lead to a significant in the total program costs. 
The was also to In antenatal population HIV 
prevalence. analysis showed that the "' ..r.""..," ..... costs significantly when 
implemented in a where antenatal population and the HIV prevalence are 











numbers of 	 _TU."HnlP women VCT which was found to be 
driver of program costs. of the resources used 
to conduct both screening confirmatory tests on those found to be HIV-positive. 
On the other hand, cost reductions increase as prevalence declines. 
arguments that prevention primary infection remains one most 
methods combating HIV as outlined in pronged to 
PMTCT Health 2004). 
The multi-way analysis shows the in the estimated total costs the 2008 
scaled up Combining case scenarios show that 2008 
program cost could possibly approximately US$ 
million. Such imprecision used in field 
data only two pilot sites due to limited time and resources. to 
increase these should be using more as the 
6.7 Resources 
6.7.1 resource gap 
Apart from financial requirements, effective implementation the scale up 
quantity and quality of staff deployed in the health system. 
Most world, including Zambia, lacked '>n,..,.n.""..' 
personnel, and infrastructure to such (World 
Organisation findings such statements. Based on 
levels in it is estimated an additional full time 
equivalent midwives would be to reach proposed 2008. 
When numbers are in view of the 2005 midwife to population ratios 
levels of production from schools, it is estimated numbers 
midwives would only able to handle the 2008 PMTCT staff requirements. 
In absolute terms this translates into a shortfall 454 by the end of 2008. 
The low of annual (150) and attrition rates shows that 
production 	of has not kept pace with especially with the ever­
~.~~, ...".... brought about by HIV/AIDS and resurgent 
Anecdotal suggests the attrition rates within nursing 












" ....and donor ......A ..... programs as are tempted access to 
training and associated allowances, transport and allowances 
of Health 2005b). continued shortages of critical public 
sector will undoubtedly efforts to scale up PMTCT The 
such shortages heavily at the delivery which is the health 
facility. When staff are not on duty, the clients do not get Equally in 
busy facilities, there are many missed opportunities for VCT services 
are most likely to be given that 80% (378) of the 476 midwives would 
for A study by et al (2003) Lusaka attributed 
the failure rate at the stage of HlV testing/counseling to lack 
staffing in facility. missed opportunities impact 
on the effectiveness of the program. 
6.7.2 Cost of required Personnel 
staffing proposed for the up of PMTCT entails increases in cost of 
employing such ca(lre:s. cost new establishment would increase 
proposed annual budget of US$90 to US$92.4 (Ministry 
Health 2005b). must be and affordable 
with national policies and One way to current 
and within MTEF would be to staffing levels 
non-formal health professionals traditional birth 
attendants, community health nurses). is an area that should be to 
extend coverage and address distributional imbalances. is evidence to "u~;,!;"'". 
that the performance standards achieved by non-health particularly in 
delivery of HIV/AIDS services, is as high as health professionals and that loss 
rates among cadres is lower than that professional staff 
(Huddart, Furth et a1. 2004). while IS a key 
increasing staffing levels, other must also inform decisions on 
Factors such as availability and quality of capacity and to 
produce the numbers, the functioning of human resource planning, 
management to deploy them should also inform 













6.7.3 Cost of training 
With an estimated deficit 454 FIE midwives in 2008 for the PMTCT and 
high to population ratios, greater in increasing the number annual 
should be Training need to strengthened to produce 
the required quantity quality of required in public sector. It was also 
~,,."~.."'.v.... that approximately US$ 413,000 would be required to provide in-service 
the 476 midwives. However, given attrition rate and expected 
need training in the this is likely to higher. 
A study by Huddart (2004) estimated that if this training was provided to health 
care workers in all hospitals and urban health centers, and two health care workers in 
all health centers, then the total cost would be nearly US$3.9 minion. Possible 
on such a cost by incorporating PMTCT training into 
the pre-service training curriculum all health workers. Currently training 
is not properly integrated and coordinated, leading to 0.E.uu,.....,,'u line 
IJVAJ,'U~AJ,F'. at 4 weeks training programmes at expense of 
providing PMTCT training would equip health 
workers with the necessary skills, knowledge and to undertake 
responsibilities and new of service provision. Training health 
like nurses would help to capacity to deliver services as VCT 
does not H""'",,,,,,,,,';U need to conducted by midwives. In addition, midwife 
training can only taken after a nursing qualification been obtained. 
while option of direct into training produce greater 
in a time, it should be noted that such specialised cadres will have 
limited career reH)DrneIlt and advancement opportunities, which may make the 
recruitment and for this cadre 
6.7.4 Health Facility Staffing Levels 
World Organization (WHO) recommended the following 
Staff/Population 1:5,000 for and 1:700 nurses (Ministry 
Health 2005b; World Health '5<4"'''"""-,,, (WHO) 2006). on this analysis, it 
could be observed that the nurse to population ratio for Zambia is 
approximately times lower than the recommended WHO population 
nurses. to such staff to population ratios, workloads 












staff morale, productivity and the quality health services. In such 
motivation is likely to be a >LA",,,,A,, challenge as view 
new activities as PMTCT as an Due to 
some the staff have even forced to take up additional roles 
data collection, hospital administration and management, have 
distracted them from the core business of providing clinical With a 
already to provide basic the quantity and quality of 
services will Indeed, all staff were in that 
are too many increase work from 
"v,,,,,,,,,,uUf",, testing and follow up of clients. is implemented as part of an 
reproductive the PMTCT are not paid any extra allowances 
government. However most of the interviewed were aware that some 
are the counselors facilities. 
was considered demotivating since the other staff that are not getting 
COlnpem;at(~a felt they were doing the same if not more being 
compensated. 
challenges are compounded by disparities in in favour 
urban areas. Analysis of the urban and health facility levels in 
study shows disparities. The urban facility had 4 midwives, 2 
midwives, 4 nurses, nurses and 2 doctors, while the 
rural facility had no midwives, 3 enrolled midwives, 1 registered nurse, 7 
enrolled nurses and 1 doctor. imbalances are a of a number of 
nu'u'\,"C which uncoordinated methods, procedures, 
personal preferences, poor rural and socio-economic considerations 
(Kombe, Galaty et al. 2004). Such have proved to obstacles to 
scaling up and providing health services to populations shortages are 
even more severe the urban areas. Zambia, there are disincentives to 
work in rural areas, which encourage to defect. Poor transport, inadequate 
educational for children an absence and 
stimulation are some of the reasons why rural practice unattractive. Health 
professionals are educated and rural living lacks stimulation that 












schools their children, no social no electricity to read or even 
stimulating conversation to be had. Transport away from these areas is likely to 
or extremely unreliable (Huddart, et a1. 2004). are now 
growing concerns to address problems, as the system struggles to meet 
demands imposed on it by the HIV/AIDS epidemic (World Bank 2004). 
In summary, human resource shortages are caused by a number of factors. 
include: 
• 	 Inadequate conditions service (pay, allowances and incentives) 
• 	 Poor working conditions (facilities, supplies and equipment) 
• 	 Weak resource 
• 	 Inadequate education training systems 
It is predictable that unless are addressed alongside 
constraints on the delivery PMTCT, care will not available on an 
accessible and equitable basis many Zambians the future. The 
raised that programme to strengthen the staffing III 
both remote urban locations a based integrated approach. 
Several initiatives can be applied at various levels within the sector, aimed at 
addressing human resource crisis. In the long run, initiatives will have to 
include (Ministry of 2005b; World Health Organisation (WHO) 2006): 
1. 	 Making more attractive through improving conditions of (pay, 
allowances, and incentives) and workplace environments. 
2. 	 Taking of any disparities of introducing 
conditions that attract critically to areas greater such as 
rural areas. 
3. 	 staff more efficiently through improved HR 
management and practices. include improving the rigour and 
transparency of recruitment, selection, and deployment procedures. 
4. 	 training institutions to produce quantity quality 
of required to scale PMTCT. 
investigation will needed throughout the implementation period the 












information to develop most appropriate strategies to retain 
u,n,,...,.,,,. cadres. these initiatives lead to of costs to government, 
they need to costed and budgeted for accordingly. 
6.8 Limitations 
are 5 UHI."...,V"'" that been identified in study. limitations 
are discussed below and where possible, the steps to limit possible bias 
are explained. 
1. The model In this uses a number assumptions in ........,vllJu.1". 

various '-Vll'-".",.'JU", which include the costs of ""AU""", These assumptions 
include a lifespan of 20 for buildings, 10 for equipment and 
vehicles, 5 for training and computers, the '-U(UlJ;<:.'"' rate, of 
discount rate (3%), 550,000 annual antenatal populations and antenatal 
HIV prevalence. addition model assumes that the intervention can 
standardized and at same of eIIlCH:!nc:y as encountered 
the facility, supplies are dependable, and current mode delivery 
requires that the service replicated, including infrastructure and 
requirements. Although these 'I.H"~"" will vary geographic regions 
time, the assumptions used in study have been based on available data 
and are explicitly stated to allow the to assess for themselves whether 
any modifications are needed the to have greater "'''''"1"'"," to 
settings. 
Due to limited resources time, only two were randomly to 
assess costs associated with the PMTCT program. Although there are no 
clear guidelines or agreement in literature on the number of facilities that 
<>UVUIU be examined, limited of may not have captured the 
full variations costs associated with settings, prevalence, 
and efficiency in delivering the In reality such an exercise would be 
costly and time consuming. Therefore study uses analysis 
to assess some of the uncertainties around the cost to examine the 












The costs associated with the private sector, activities at the central 
administration costs) and provincial (e.g. monitoring and evaluation 
costs) have from the study. costs associated with 
establishing a PMTCT program in a private health facility are likely to 
higher than that of a public facility owing to the higher costs of labour, use 
more costly medical supplies, and equipment. Even though the costs of 
the private sector are important to examine, they are unlikely to the 
costs in scaling up the public sector program that caters for the 
majority of the Zambian population. initial of scale up program 
included the establishment of capacity at central provincial to 
provide leadership in the scale up program to the district Currently 
these structures are place and fully The lies 
u~~u.." ... up the actual delivery in health to the 
proposed and uptake targets. this study focuses on the 
costs required to deliver the PMTCT program at public health facility level 
and the costs associated with provincial and central management have 
4. 	 There is a possible bias in use constant unit costs to estimate the costs of 
scaling up PMTCT Zambia. This method is at odds with basic economic 
theory as it the possible of that are associated with 
scaling up service delivery to the proposed national targets Campaign 
for (ACT africa) 2001; Kurowski et a1. 2001). In 
reality, starting from a point scaling up is likely to 
accompanied decreasing unit costs. These economies scale relate to 
in resource use as the becomes more familiar to over 
which could partially explain why the older urban had lower unit 
costs. Once a certain level is reached, additional investments in infrastructure 
and higher costs delivery in rural areas will result rising unit costs 
(AIDS Campaign Team Africa (ACTafrica) 2001). Ideally total costs 
scaling unit costs that have been adjusted 
different of HIV prevalence, and infrastructure 












Kumaranayake, Kurowski et al. 2001). Therefore the use of unit costs from 
the urban facility could underestimate the true costs of scaling up at higher 
levels of coverage (AIDS Campaign Team for Mrica (ACTafrica) 2001). In 
order to lessen this possible bias, this study uses the higher calculated unit 













SUMMARY, CONCLUSIONS AND RECOMMENDATIONS 
7.1 Introduction 
is the chapter the study that gives a major 
These are summarized with regards to the objectives of the 
given in the first in order to evaluate whether the study has achieved what it 
set out to do. Section therefore a summary of the key findings in relation to 
the In the recommendations study are 
while sec:nou 7.4 gives ;:'Ul',/",,,"'U,JU':' further related to this study. 
7.2 Summary of key Findings in relation to the research objectives 
findings of the study are summarized in the context of the following 
Primary costing objectives: 
• 	 To the direct care cost mother attended to VCT 
services, delivery and follow up in pilot sites from a 
• 	 To determine the current human resources used to provide PMTCT in the 
pilot sites 
• describe organization and management PMTCT in study pilot 
ModeJed costs of scaling up related 
• 	 To health care costs associated with scaling up PMTCT 
to national targets. 
• 	 calculate proportion of the health that will be used to 
up PMTCT to all districts. 
• 	 To estimate the workforce to scale PMTCT 
• 	 To develop appropriate policy recommendations based on study findings. 
7.2.1 Primary ,-,,,,~.,,,...,,... in the health facilities. 
total costs of providing PMTCT were to be US$29,000 
and US$62,000 in the and urban facilities respectively. differences the 
two facilities were not related to efficiency per se but rather to in 
mIX, levels, and utilization patterns. urban had approximately 3 












resources in that However, the average costs were lower in urban facility 
as it had a proportionately output for inputs used. This could point to 
potential of as costs were spread over more people in the urban 
Analysis of cost profiles the facilities shows that the majority of total costs are 
recurrent costs. Recurrent costs accounted for 80% and 88% total costs 
rural and urban respectively. In both personnel costs were 
largest followed by costs associated with testing supplies. findings 
suggest that nevirapine costs are no longer major cost 
published studies. advent to administer 
Nevirapine tablet and susoeIlSlClll (US$0.03 per ml) provides a unique 
opportunity to avail this treatment to numbers of women in resource 
constrained When the total costs were allocated to the PMTCT pn),gram 
components it was found that VCT ( testing, counseling) 
costs were the largest accounting for 84% of total costs in both facilities. 
This was of the number of women that underwent VCT and high 
costs of the HIV testing Kits. that services form entry point for 
PMTCT and generally have such important ~u~.<u.., in terms enhancing HIV-
prevention messages and timeously identifying HIV -positive people who be in 
of care, support and treatment, lowering costs associated with testing is a key 
challenge. 
The direct health care cost per mother attended to VCT was 
1.58 in urban facility US$ 21.94 rural The cost 
per mother and baby set adhering to treatment delivery was US$ 8.37 in 
urban facility and in the rural facility. average cost mother 
baby set testing was US$ 17.82 in facility US$ 
in the rural facility. higher rural unit costs give some indication of the 
diseconomies of scale are as the ~.......... expands to these areas. 
Although efficiency was not assessed in study, it indicates equity rather 










7.2.2 Organisation and Management of PMTCT services in the Health facilities 
The importance of pilot unit cost findings depends on extent to which they 
can be generalized. Therefore an understanding of model of service delivery is 
key to understanding uptake the and some of problems in service 
delivery that may hamper scale up In each the facilities PMTCT is 
offered as part of a holistic and integrated reproductive health care package 
antenatal clinics. PMTCT has linked to other such as provision 
of tetanus toxoid, malaria and anemia prophylaxis, promotion of care and 
provision of planning ANC a one-stop shop for 
Other factors contributing to continuum of care include 
health good and steady 
supply of consumables strong political support local politicians and 
community members. 
In of the facilities the program was and provided by trained midwives. 
utilization in both revealed a cascade decline those offered 
counseling to who eventually went on to enter the program and 
adhere to the national guidelines as outlined in Appendix 1. There was a high 
acceptability as over 90% of clients were counseled 
opted to on to Of that went on to tested 22.53% 25.02% were 
found to HIV seropositive in urban and rural facilities respectively. The 
prevalence significantly exceeded national antenatal mv prevalence 
19% potentially to self-selection among antenatal attendees. Although with 
more than 90% acceptance of testing, it could also be that facilities were based in 
areas with HIV The findings show that were 
significant drop outs at the point of entering the PMTCT program, delivery follow 
up. The out rates during delivery are closely related to the fact that only 61% of 
the nationwide are supervised and the 39% 
at home. Follow up is most difficult component due to stigma, lack of 
PCR testing for exposed babies, shortages and lack of transport. The wide 
provision PCR would not help to quickly the 












lengthy 18 month cotrimoxazole prophylaxis regimen all HIV exposed babies 
while awaiting an test. 
Cost of scaling PMTCT 
Zambia's HIV rates are among highest the As part of the 
response to this epidemic initiated pilot PMTCT in 1999 and is now 
in the of up the service to desired The estimated direct national 
costs scaling up PMTCT were based on expected utilization under national 
targets 97% antenatal clinic utilization, utilization, 75% adherence to ARVs 
during delivery, adherence to follow up testing and the calculated unit costs form 
the pilot The HIVNET012 PMTCT may be relatively cost-effective but 
the that the national costs of scaling up be substantiaL 
In 2005 discounted US dollars, the cost 5.7 million in 2006, US$ 
8.4 in in 2008. This would amount to a total million 
over the year period (2006-2008). a proportion of the total health 
budgets, it was found that the PMTCT program would account for 4.2% 2006, 
4.8% in 2007 and in 2008. As a of the pattern utilization, VCT 
was found to account at least 70% of total annual PMTCT costs. Comparing 
the estimated costs the scale up program to the proposed health 
allocations show that there would budgetary constraints if the program to 
meet its The analysis shows that would be a total deficit of 
approximately US$5.06 million over the three period (2006-2008). Such a 
deficit would hamper efforts to allocate adequate resources that would ensure that the 
desired utilization levels achieved. The by policy to overcome 
such deficits must analyzed context underlying macroeconomic constraints 
that have our nation. 
The level funding which Government of Republic of Zambia can 
to health is by the overall status the which limits 
total revenue available to allocate to health. Currently between 10% and 1 of the 
total government budget is allocated to the health sector, but is room for 












scarce capacity, time resources away core o£\,,,prn1'T1'p 
In addition it has it difficult to the actual amounts that are 
spent on scaling up interventions including PMTCT. Finally, the vertical 
segregation of such donor funding flows seriously hampered government's efforts 
at medium- and long-term planning. 
of the analysis other studies indicate 
that the management of staff time could be biggest of the up 
Program. inefficient use time could potentially lead to increases in 
total cost of the 2008 scaled up were found 
to associated with HIV prevalence, the use primary 
prevention as outlined in the international four pronged approach to PMTCT. 
7.2.4 Human Resources 
The success of the up program depends on having the quantity 
and quality of human resources to deliver services. analysis of human 
resource requirements to meet the proposed 2008 scaled up utilization targets 
the levels production of too low to meet the 
required numbers in the public sector. of the analysis are; 
• 	 Need outpaces production ofhealth workers: based on the efficiency levels in the 
pilot sites it was estimated that FIE would be required to meet 
proposed 2008 up However the attrition rate (4%), annual 
graduates (150) and current public sector levels are factored in, a considerable 
human resource gap appears. The shows that would be a 
454 midwives in 2008, which would into a 95% III 












made to address these shortfalls, Zambia would serious constraints m 
meeting the proposed coverage ._.",,_.~ 
• of new personnel: cost employing the additional 476 midwives 
would entail an increase in health sector salary budget the<UU,lU(U 
allocated US$ 90 million to million. However given that 
the health budget would be under, this may not be affordable 
""-'AUU';"', Therefore further exploration must be made to increase the levels 
of more multi-skilled non-formal health non health professionals (e.g. 
traditional birth attendants, community health The use of trained 
traditional birth attendants (fBAs) would allow them to assist in deliveries and 
contribute to PMTCT With training they would to perform mv 
testing using the prick method. strategy is likely to increase the 
number of women tested offered PMTCT 
• 	 Training: production and training of midwives has not pace with health 
sector needs, both quantitative and qualitative, to the increasing 
burden disease as a result of mY/AIDS and to cater and 
expanding health worker roles and new forms of provision. The low 
numbers of annual graduates reflects lack of capacity of the training institution 
to response to the challenges posed by HIV. The training midwives for the 
scale up PMTCT is currently conducted as usually at the 
",,,,~....'A">"" of providing clinical for up to 4 weeks. is counter intuitive, 
given that the costs of the PMTCT program have shown to be sensitive to the 
inefficient use of time. Incorporating PMTCT training into ore-selrv 
training may benefits. 
• 	 Staffing levels in the pilot facilities: The show that there are 
geographical disparities in staffing skewed in favour of the urban facilities. The 
urban had 6 midwives whom 2 were midwives, while the 
rural facility had only 3 enrolled midwives with no registered midwives. Such 
imbalances extra challenges to scaling up services areas. 
imbalances are as a result a number factors uncoordinated 
recruitment methods, weak procedures, lack 
financial top-up salaries staff in remote areas, group 












transport, renovation of houses, electrification solar in remote areas, 
career progression) (Kombe, Galaty et al. 2004). 
feasibility scaling PMTCT to proposed levels will largely depend on the 
success of to ~~'AL ~"u the and resource constraints that 
have highlighted this study. The unprecedented commitment by international 
organizations and governments, the of and 
antiretroviral make feasibility scaling up PMTCT a real possibility 
even a resource setting like Zambia. 
7.3 Recommendations 
following recommendations are based on research findings of study: 
.. study that since largest in the PMTCT national 
.....r,,,, .. ,,,,.... is the costs efforts should be to scale 
testing with cheaper but effective testing methods. These methods use 
of finger prick and based testing of blood with 
syringes. would also allow trained non-formal health personnel (e.g. 
to in conducting VCT 
.. study reveals that would be financial constraints on 
government resources should the PMTCT scale up program reach its proposed 
targets. A recommendation is made that government make greater efforts to 
identify, mobilize allocate adequate resources to the up 
program for it to succeed. Government should advantage of additional 
resources from sources such as PEPFAR, GFATM and HIPC savings to 
allocate greater amount of resources to the program. 
.. are currently no accurate data on the funds that are being on 
HIV/AIDS interventions. is partly as a result the international 
and vertically allocating directly to implementing facilities 
and the of a public expenditure tracking system. The Ministry of Health is 
recommended to take the lead in streamlining funding into established funding 













tracking system to link expenditure to the nrnnnc outputs of the PMTCT 
up program. 
The drop out rates at point of entering program, delivery 
up are to return on 
The following measures are recommended to uptake rates in 
.. 	 Increase community participation by male involvement the VCT 
component of the PMTCT program. is also likely to help stigma and 
increase numbers of HIV positive women that eventually into the 
PMTCT program. 
.. It is also recommended that in non-negligible n .. r'...." ..' women 
that at home, the role of should be expanded to provide VeT 
supervise NVP llJ<.',"U'Vll, follow up mothers in community and refer 
mothers and babies for postnatal checkups. 
.. The study provides evidence that primary prevention of HIV would effective in 
""Y'"''''''' the overall costs the up program. It is recommended 
that current selective on NVP revert to the 
agreed 4 which includes on pnmary 
of HIV infection. 
shows that the current and disparities the level of staffing in 
the facilities are a the scale up intervention to 
such a human resource would have to Based on the 
Ull'",UA/:;e> the following rec;onlmlemla have 
.. 	 Introduce financial and non-financial incentives: introduction of LAB«U'''"L 
incentives (e.g. top-up for staff in remote areas, group perfonnance 
incentive schemes) and non-financial incentives (provision of transport, 
renovation of houses, electrification using solar in remote areas, faster 












• 	 Improve HR and develop systems and practices: 
recruitment deployments on existing imbalances In "'(.4,;,,1... ,,[<, levels 
would help to "hIJU1,'U PMTCT to the rural areas. 
• 	 Greater investments in pre-service training: it is recommended that more 
resources used to training midwives to 
produce a number of graduates with the required skills to pace 
with the levels required to PMTCT. 
• 	 Reconfigure staffing pattern: staff costs are a significant cost driver, using 
care Community workers, traditional birth 
attendants) new roles such as lay counselors would help costs of scaling 
up. Although cadres would help to meet requirements scaling up, 
there is no evidence available locally that quality of care would not be 
compromised. It is therefore recommended that the new cadres adhere to strong 
quality assurance measures and should supervised by a trained health 
professional. 
7.4 Further ,I,"'!;~'''''''. 
The following are suggestions further research: 
"'V,",lVL,U.!1. is need to conduct a costing study from the perspective to 
determine the costs that are borne by the clients and families. 
2. 	 ,",...,,.n,,F. model in study looked at one PMTCT delivery model. 
hCC)nC)mllC evaluations should be conducted on possible alternative scale 
which would also evaluate models of VCT. 
the cost implications prescribing cotrimoxazole all exposed infants and 
to follow-up that was with '''''UUF. babies at 18 months 
this protocol, an evaluation versus 
conducted to 	 whether savings in cotrimoxazole costs would 
the higher costs of the PCR tests. 
3. 	 outcomes to information on the 












should evaluate the actual effectiveness of the the 
"-'....' ..VA ....... 
context. 
investigation will be needed throughout the 1IDIplememtIHl()n "',,, .... ,,.,, of 
up order to track and analyse expenditure, attrition 
rates and to use this information to develop most 
ess:enltlal health worker cadres. 
to carry out a at 













Appendix I: Antenatal Care Follow Chart 
Pregnant women presenting for booking 
I I 
",. 
Group Education and Information I I 

~ 
I Individual pre-test counseling 
~ 

Counseling register I I 

Opted out of HIV I. 1TestingI .. 

Do rapid testing~ I I 
Proceed with booking and _____ 1 
encoura!!e testin!! at a later date I I ..... 
I" HIV +ve and 2nd HIV­
1" Negative = HIV - (Negative)
I I" + 2
nd test positive =HIV+ (Positive) I I I II 
ElisaI I------...~--
HIV Negative.L-----t HIV positive I I ~ 

Blood test register Blood test register 
I I I ... ... 
Post-test counseling Post-test counseling I I I ... 
Counseling register Cou,nseHog registerI I I ., 
... Proceed with booking etc . I I 
I Mark Antenatal card I ... 1 
I Re inform: MTCf I I Proceed with booking 
I I
Consent 1 Yes I Encourage retesting later in oreQllanCV.. 
l Mark Antenatal card I Referral to : 
I No I • -J 
Post-test clubs, health 
education activities 
I Proceed with booking I NVP: at +/- 30 weeks: dispense NVP 200 mg for when labour starts. 
2mg/kg to baby within 72 hours of birth . .. 
Labour ward and under five registers 
.. - , ~ ., I 
Repeat 
Info on Referrals to: 
PMTCf at next 
vic;;,itc;;, 
1) PCP prophylaxis 3) Post-test clubs and peer-support groups 












Appendix IT: Antiretroviral Prophylaxis Regimens for MTCT prevention 
(Summary of evidence) 















twice a day 
starting at 36 






onset of labour and 
every 6 hours until 
delivery 
NVP 200mg single-
dose at onset of 
labour 
Infant: 





ZDV 4mg/kg twice 
a day for 7 days 
starting immediately 
after birth 




ZDV 600 mg at 
onset of labour and 
single dose NVP 
200 mg at onset of 
labour 
OR 




ZDV Mother: Mother: ZDV 600 None VTR 15.7% in 
(Ivory coast ZDV300 mg mg at onset of intervention ann 
CDC short- twice a day labour versus 24.9% in 
course ZDV starting at 32 OR placebo at 3 




ZDV 300 mg at 
onset of labour and 













None None Infant: 
NVP 2 mg/kg oral 
suspension 
immediately after 
birth and ZDV 4 
mg/kg twice a day 
for 7 days. 
When ZDV oral 
suspension not 
available, NVP 2 
mg/kg as soon as 
possible after 
delivery and a repeat 
dose of NVP 72 
hours after birth. 
Overall VTR at 
6-8 weeks 15.3% 
in NVP+ZDV 
arm and 20.9% 
with ZDV only. 
VTR at 6-8 
weeks in infants 
who were 
negative at birth 










200 mg at onset of 
labour 
Infant: 




VTR 15.7% in 
NVP arm vs. 
25.8% in ZDV 



























Appendix 'HII..IUUiU Demographic and Epidemiological Data Collected 
Data Item 




2005 Central Statistical Office web 
htt ://www.zamstats. 




Health Management Information 
S stems, Central Board of Health 
2005 Health Management Information 














Appendix IV: Interview Schedule Used at level 
person being 
Title 
Duration in Current 
(i) 	 When did begin 
services 
in Zambia? What are the 
objectives in Zambia? What is the 
Rationale 
(ii) What criterion 
(iii) 
Was a 	 before the "..." ..v ........ 
To What has PMTCT 
Stakeholders (Who is responsible 
scaled up In Zambia? List the Major 

advocacy and resources mobilization, 
Policy and 
(iv) 	 How many full time and part-time are to PMTCT level? 
this What additional is required? ( collect salaries) 
(v) 	 How would you describe the PMTCT program, a Vertical or Integrated 
program? Why? 





(vii) What percentage of the National health does PMTCT/ 
receive? Is there a Budget line for PMTCT in the National Budget? 
(viii) program is funded? 
Process been llHAlH.J;v..... How is process organized? (ix) 
(x) 	 What structures are in at National, provincial and National level to 
coordinate the PMTCT activities? What is the relationship with the various 
stakeholders? 
(xi) based ~.~.....~,~ for the community( 
(xii) 
(xiii) 
How has the scale up ,",Uj;UI','-'U the private sector/industry in \J"'t....., ... up? 













(xiv) What have the constraints to Scaling up to 
targets? What lessons have learnt so far? 
(xv) 	 What have the successful areas during this process? What have been 
the failures? 
(xvi) 	 How will program What kind assistance are 
receiving? 
(xvii) 	 Would you describe the up as affordable sustainable? 
(xviii) What are 	 policies that to guide program implementation? 
reqUlres a planning to meet ~~A""''''F> "'J,",U'''. 
~''VI-'''''F. national management protocols and 
monitoring systems. What structures are in and how will 
achieved? 
(xx) cornerstone of the '"''''IJaiJ:",.U'H 	 capacity development. 
you 	 hope to recom::ue greater capacity with the 
Resource 
(xxi) What modalities are in place to ensure that duplication III 
is avoided? there any challenges capacity 
development and how will these be ( Training Materials, 
Quality numbers of skills mix, HR 
plan) 
(xxii) 	 training of Pre 
Follow up 
(xxiii) 	 the Information systems for capturing PMTCT Data? (e.g. 
Indicators, Linkages, Consolidated Private and Public, time ) What 
llTIprc,vements need to to and 
(xxiv) 	 any quality assurance measures that have been put place and 
if so how are they 
(xxv) 	 would you the political commitment to Scale up 
How has MOH expressed commitment? 
(xxvi) 	What is the current for 
positive mothers 
(xxvii) effective has Program preventing infant infection? 
(xxviii)Could you highlight any other recent policy developments in the Scale 
program? 
we could start over what would you do differently? 












Appendix V: Interview Schedule for Site staff 
Name of person being Interviewed _________ 
Title 
Duration in Current position. _________ 
(i) When was the PMTCT program 
Please describe 
implemented in 
every stage. How 
that has 
that are used at 
Please describe the >AU""V'''' 
program. Are there any ''''-''''H. 
are in the (iii) 
(iv) 
relationship with the 
How is the program being """'lUE;;''''''' 
(v) What goals have been set out 
targets to be met? 
the program? Do you have specific 
(vi) How has the program by the community and Staff? 
(vii) What have been the 
PMTCT program? 
you have been facing in implementing the 
(viii) What are the success and 
the program? 
you have encountered in implementing 
(ix) Is there anything 
program? 












Appendix VI: Ethical clearance granted by the Research Ethics Committee of the 
University of Cape Town 
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Appendix VII: Consent Form for Participation in the Study 
STUDY TITLE: The Economic Feasibility and Potential Impact ofScaling Up PMTCT in 
Zambia 
Principal Investigator: 
Mpuma Kamanga, MPH Student, University of Cape Town 
The University of Cape Town and the Central Board of Health are conducting a study on the 
economic feasibility and the potential impact of scaling up prevention of Mother to Child 
Transmission of HIV services in Zambia. The study will involve the collection of PMTCT 
facility based utilization and cost data, and interviews with key personnel involved in the 
provision of PMTCT services. The findings of the study will assist policy makers to 
understand the cost and resource implications of the scale up of PMTCT services. It will also 
contribute to the limited knowledge about resource requirements for scale up and will form a 
base for further cost-effectiveness studies in this field. The study poses no risk or physical 
hazards, pain or discomfort to any of the participants. 
In connection with this, I would like to ask you some questions regarding the PMTCT 
services in this facility. Your participation is entirely voluntary and you have the Right to 
withdraw from the interview whenever you desire. All the information you will provide will 
be kept confidential, and I wish to assure you of complete anonymity with regards the 
information that will be provided. If I have your permission to proceed with the interview, 
please, sign the declaration below. 
The Research has been explained to me and I understand what will be required of me if I take 
part in the study. The research team led by Dr. Mpuma Kamanga has answered my questions 
concerning the study. I understand that, at any time my organization and I may withdraw 
from this study without giving notice. 
Participant____________ Signature__________________________ 












Appendix VIII: Costing Model Results for The Rural Health Facility 
Costing in Rural Facility ( 2005 US$ prices) 
Sub Total 
Rural facility Variable costs 





% time spent 
6,640.45 
Total Costs (US$) 
6,640.45 
B) Drugs Unit costs (US$) Dosage per client Number of clients Total Costs (US$) 
Nevirapine 200mg tablet 0.224/tablet 1 ml 229 55.85 
Nevirapine Suspension 0.031/ml 0.6 ml 199 3.75 
cotrimoxazole 0.006/ml 130 mis/month 23 336.38 
Sub Total 395.97 
C) Medical Supplies Unit costs (US$) Quantity Allocation Basis Total Costs (US$) 
I) Testing 
Determine Abbot Test Kits 1.38 1075 Direct (100%) 1,482.43 
Genie II Test kit 3.69 269 Direct (100%) 993.62 
EDTA Tes t tubes 0.72 1075 Direct (100%) 776.51 
Red Top Tes t tube 0.72 1075 Direct (100%) 776.51 
5ml Syringes 0.05 1075 Direct (100%) 52.94 
examination gloves 0.06 2150 Direct (100%) 134.12 
21g needles 0.03 1598 Direct (100%) 47.21 
Cotton Wool 6.24 148 Direct (100%) 923.27 
Methylated spirit 5.58 24 Direct (100%) 133.96 
Sodium Chloride (bleachL 2.46 70 Direct (100%) 172.38 
Medicated hand soap 0.49 40 Direct (100%) 19.70 
Needle Waste containers 0.82 96 Direct (100%) 78.80 
SubTotal 5,591.44 
ii) Delivery Supplies Unit costs (US$) Quantity Allocation Basis I Total Costs (US$) 
examination gloves 0.06 398 Direct (100% 1 24.83 
Methylated spirit 5.58 12 Direct (100%) 66.98 
Sodium Chloride (bleachl 2.46 50 Direct (100%) 123.13 
Medica ted hand soap 0.49 55 Direct (100%) 27.09 
Needle Waste containers 0.82 36 Direct (100%) 29.55 
Maternity pads 0.25 796 Direct (100%1 196.02 
Cord Clamps 0.49 199 Direct (100%) 98.01 
IV Cannula(18g) 0.76 299 Direct (100%) 225.42 
SubTotal 791.01 
iii) Follow up Supplies Unit costs (US$) Quantity Allocation Basis Total Costs (US$) 
ELISA test Kits 0.53 46 Direct (100%) 24.47 
Yellow Tips 0.03 100 Direct (100%1 3.28 
Icc Syringe 0.26 100 Direct (100%) 26.27 
Sub Total 




D) NOD-Medical costs 





Total Costs (US$) 




Total facility costs 
(US$) 









Total Costs (US$) 
Electricity 10,530.52 % of visits 0.14 1,474.27 
Water 1,560.08 % of visits 0.14 218.41 
SubTotal 2,457.12 























Appendix IX: Costing Model Results for the Urban Health Facility 
Costing in Urban Facility (2005 US$ prices) 
Urban Facility Variable costs 
Gross Annual 
A) Personnel Number Salary (US$) Allocation Basis 
Midwives 6 4,989 % time spent 
Sub T.otal - .. 
B) Drugs Unit costs (US$) Dosage per client Number of clients 
Neviragine 200mK tablet 0.224/tablet 1 ml 841 
Nevirapine Suspension 0.031/ml 0.6 ml 631 
cotrimoxazole 0.006/ml 130 mIs/month 259 
SubTotal 
C) Medical Supplies Unit costs (US$) Quantity Allocation Basis 
I) Testing 
Determine Abbot Test Kits 1.38 4,417 Direct (100%) 
Genie II Test kit 3.69 995 Direct(loo%) 
EDT A Test tubes 0.72 4,417 Direct (100%) 
Red Top Test tube 0.72 4,417 Direct (100%) 
5ml Syringes 0.05 1,075 Direct (100%) 
examination gloves 0.06 8,834 Direct (100%) 
21g needles 0.03 6,611 Direct (100%) 
Cotton Wool 6.24 98 Direct (100%) 
Methylated spirit 5.58 30 Direct (100%) 
Sodium Chloride(bleach) 2.46 49 Direct (100%) 
Medicated hand soa~ 0.49 24 Direct (1ooo/~ 
Needle Waste containers 0.82 36 Direct (100%) I 
SubTotal 
-'.-. 
ii) Delivery Supplies Unit costs (US$) Quantity Allocation Basis 
examination gloves 0.06 1,262 Direct (100%) 
Methylated spirit 5.58 10 Direct (100%) 
Sodium Chloride(bleach) 2.46 52 Direct (100%) 
Medicated hand soap 0.49 36 Direct (100%) 
Needle Waste containers 0.82 24 Direct (100%) 
Maternity pads 0.25 2,524 Direct (100%) 
Cord Clamps 0.49 631 Direct (100%) 
IV Cannula(18g) 0.76 947 Direct (100%) 
SubTotal 
iii) Follow up Supplies Unit costs (US$) Quantity Allocation Basis 
ELISA test Kits 0.53 518 Direct (100%) 
Yellow Ti~s 0.03 100 Direct (100%) 
Icc Syringe 0.26 100 Direct (100%) 
SubTotal 
.' 
Total facility costs 
D) Non-Medical costs (US$) Allocation basis Allocation factor 
Transportation 7,589.32 % of visits 0.24 
Maintenance 6,324.44 % of visits 0.24 
Stationary 13,660.78 % of visi ts 0.24 
SubTotal 
Total facility costs 
E) Utilities (US$) Allocation basis Allocation factor 
Telephone 4,857.17 % of visits 0.24 
Electricity 9,360.17 % of visits 0.24 
Water 1,821.44 % of visits 0.24 
SubTotal 
Total Variable costs 
I ' .~1·i ~',~, , 
Total Costs (US$) 
19,619.63 
19,619.63 
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